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Abstract 
Studies suggest that eating disorder (ED) pathology may be linked to ovulatory and 
unexplained infertility in women who present to reproductive treatment centers.  Specifically, 
studies have linked hypothalamic amenorrhea, oligomenorrhea, and anovulatory cycles to 
disordered eating.  Advances in Assisted Reproductive Technology can lead to successful 
conception for women with ED; however, they have a higher risk for poor maternal and fetal 
outcomes.  
This descriptive, comparative, quantitative study examined disordered eating and 
psychological symptoms in women with ovulatory and unexplained infertility compared with 
women receiving routine health care from their primary care providers.  Women ages 20 to 44 
were recruited.  After providing verbal consent, a study packet was mailed to the study 
participant’s home. 
The Eating Disorder Inventory-3-Referral Form and Herman and Polivy Restraint Scale 
measured disordered eating symptoms.  The Speilberger Anxiety Inventory and Beck Depression 
Inventory-II examined psychological symptoms.  Provisional DSM IV TR diagnoses were 
   
ascertained using the Eating Disorder Inventory-3-Symptom Checklist, along with other scale 
items.  
Ninety women were consented and 85 women (51 with infertility; 34 receiving routine 
health care) returned the packet of instruments.  Multivariate analysis of covariance 
(MANCOVA) confirmed that women with ovulatory and unexplained infertility had 
significantly higher Desire for Thinness (p = .001) and Bulimia (p = .007) subscale scores 
putting them at risk for Anorexia Nervosa or Bulimia.  Women receiving routine care had 
significantly higher Body Dissatisfaction (p = .000) subscale scores consistent with their higher 
weight and tendency toward overeating.  Women receiving routine care also had significantly 
higher Restraint (p = .000) scale scores, leaving them at risk for dietary disinhibition.  The 
groups did not differ on psychological symptoms.  Women with infertility had lifetime ED 
diagnoses many times the national ED prevalence rate, similar to the research findings of 
Freizinger et al. (2010).   
The study results support that women with ovulatory and unexplained infertility are at 
risk for having an occult ED.  The critical import of integrating ED assessment into infertility 
evaluation, reproductive and primary care was implicated.  Further study to isolate biobehavioral 
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Statement of the Problem 
 
Infertility is one of the most common chronic health disorders involving young 
adults.  Infertility is defined as the inability to conceive after a minimum of one year of 
regular unprotected sexual intercourse (Speroff & Fritz, 2005; Strigh, 2005).  Research 
outcomes reveal a potential link between eating disorders (ED) and infertility.  
Specifically, ovulatory infertility and unexplained infertility have been linked to ED 
among women presenting to infertility centers (Abraham, Mira & Llewellyn-Jones, 1990; 
Bates, Bates & Whitworth, 1982; Couzinet, et al., 1999; Loucks, & Verdum, 1998; 
Miller, Parulekar, Schoenfeld, Hubbard & Grinspoon, 1998; Stewart, Robinson, 
Goldbloom, & Wright, 1990).  Disordered eating symptoms may be a possible 
contributor to infertility, and therefore, women experiencing infertility could report more 
disordered eating symptoms than a comparison group of women receiving routine health 
care by their primary care providers (PCP).  Further study of women experiencing 
infertility was warranted to determine if disordered eating symptoms were increased in 
ovulatory and unexplained infertility, when compared to women receiving routine health 
care by their PCPs, using a carefully controlled comparison research design.  To this end, 
this study was designed to fill the gap in knowledge. 
Background and Significance 
 
Infertility   
The incidence of infertility in 2002 was 7.4% in women aged 15 to 44 years 
(National Survey of Family Growth [NSFG], 2002).  Eighty-five percent of couples 
attempting to conceive will have been successful during a 1 year period (Speroff & Fritz, 
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2005).  Clinical assessment of a couple’s fertility is indicated if a pregnancy has not 
occurred within 1 year; although, earlier evaluation is indicated in women with a history 
of oligomenorrhea or amenorrhea, women older than age 35, and women with suspected 
pelvic pathology. 
 For women, gender-related etiologic factors involved in infertility include 
ovulation disorders, tubal disease, endometriosis and unexplained infertility (Collins et al. 
1993).  Other factors, such as luteal phase defect, are included among unexplained 
infertility (Keye, Chang, Rebar, & Soules, 1995; Speroff & Fritz, 2005).  Unexplained 
factors can co-occur with ovulation, tubal, and peritoneal defects.  Duration of fertility is 
an important prognostic feature, as is age (Smith, Pfeifer, & Collins, 2003).  Overall, 
women with infertility have less than a 50% likelihood of proceeding to a live birth 
without treatment (US Congress Office of Technology Assessment, 1988).  
 Approximately 25% of infertile women in the US have fallopian tube disease, 5 to 
10% of infertile women have endometriosis, and 25% have ovulation disorders (Imani, 
Eijkemans, te Velde, Habbema, & Fauser, 2002).  Another 30% of infertile couples have 
unexplained infertility, which is defined as having normal basic test results assessing 
ovulation, tubal patency, and sperm production (Smith et al., 2003; Stewart, Robinson, 
Goldbloom, & Wright, 1990).  
Altered Nutritional Intake in Women with Infertility 
 Observational studies.  Despite limitations of small sample size and lack of 
control or comparison groups, results from early studies revealed a potential link between 
altered nutrition associated with disordered eating and ovulatory and unexplained 
infertility (Abraham, Mira & Llewellyn-Jones, 1990; Bates, Bates, & Whitworth, 1982).  
3 
 
Bates et al. (1982) found that the practice of maintaining a slim body appearance below 
ideal body weight (IBW) may result in unexplained infertility and abnormal menstrual 
cycles in otherwise well women.  When following a diet designed to increase their body 
weight to calculated IBW, almost three-fourths of the women with infertility 
spontaneously conceived and most of the women with secondary amenorrhea resumed 
their menstrual cycles.  Also, Abraham et al. (1990) found evidence of disordered eating 
or excessive exercise in women with secondary amenorrhea and ovulation failure who 
were undergoing gonadotropin releasing hormone (GnRH) treatment.  However, this 
study outcome was unclear because excessive exercise often accompanies eating 
disorders (American Psychiatric Association, 2000; Morgan, 1999).   
These early observational studies were limited in their small sample size and lack 
of adequate power.  Lack of comparison groups was also a limitation.  Finally, the Bates 
et al. (1982) study did not specifically investigate disordered eating symptoms. 
 Biobehavioral studies.  Recent biobehavioral research provided additional 
support for the link between nutritional intake and amenorrhea.  Specifically, leptin, a 
protein hormone expressed mainly by adipocytes, is an important hormone in satiety, 
metabolism, and reproductive function (Cunningham, Clifton, & Steiner, 1999; 
Mantzoros & Moschos, 1998).  In particular, support for the association between altered 
nutritional intake and infertility can be found in biobehavioral studies of leptin (Boden, 
Chen, Mozzoli, & Ryan, 1996; Maffei et al., 1996; Jimerson, Mantzoros, Wolfe, & 
Metzger, 2000; Wolfe, Jimerson, Orlova, & Mantzoros, 2004).  
Decreased leptin has been found in normal weight women with nutritional deficits 
and functional hypothalamic amenorrhea (FHA; Laughlin, Dominguez, & Yen, 1998). 
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Functional hypothalamic amenorrhea is defined as the cessation of menstrual cycles with 
no apparent structural irregularity of the brain, hypothalamus, pituitary or ovaries. 
Functional hypothalamic amenorrhea results due to a reduction in the hypothalamic 
gonadotropic-releasing hormone (GnRH) signal to the pituitary gland, resulting in 
anovulation (Ahima, 2004).  The Laughlin et al. (1998) study suggests that adequate 
nutritional intake is critically important to leptin function and, hence, conception and 
fertility outcomes.  
Leptin levels have been found to be reduced in women with eating disorders, a 
population characteristically exhibiting amenorrhea or oligoamenorrhea.  Women with 
active anorexia nervosa demonstrated significantly decreased serum leptin levels, which 
normalized prior to full weight restoration (Eckert et al., 1998; Mantzoros, Flier, Lessem, 
Brewerton & Jimerson, 1997).  Significantly lower leptin levels were also found in 
women with bulimia nervosa and recovered bulimia nervosa compared to normal controls 
(Jimerson et al., 2000).  
Biobehavioral research outcomes to date suggest that adequate nutritional intake 
may be a key factor in leptin functioning and, hence, reproductive function.  The import 
of the preceding observational and biobehavioral research outcomes is that disordered 
eating symptoms may be a possible contributor to infertility.  Therefore, disordered 
eating symptoms may be found in greater numbers of women presenting to infertility 
centers than in women receiving routine health care from their PCP.  Further study using 
a larger sample size was warranted to determine if disordered eating symptoms are 




Women Experiencing Disordered Eating Symptoms 
 Disordered eating symptoms may be evidenced in women experiencing infertility 
in a number of ways.  Women may restrict their intake of fat yet maintain a normal 
weight.  Depression or anxiety symptoms may increase or decrease dietary intake.  Some 
woman with infertility may experience EDs defined by the Diagnostic and Statistical 
Manual, Fourth Edition (DSM IV TR; American Psychiatric Association, 2000) 
diagnostic criteria.  Finally, one infertility diagnosis, specifically Polycystic Ovary 
Syndrome (PCOS), is associated with beginning metabolic changes that could increase 
dietary intake (Linne, 2004; Speroff & Fritz, 2005).        
Normal weight women with restrictive eating patterns.  Women experiencing 
infertility can have disordered eating symptoms that do not meet full DSM IV TR 
(American Psychiatric Association, 2000) diagnostic criteria for Axis I ED.  Results from 
a number of studies (Couzinet et al. 1999; Rock, Gorenflo, Drewnowski & Demitrack, 
1996; Warren, Holderness, Lesobre, Tzen & Vossoughian, 1994) implicated unbalanced 
nutritional intake in functional hypothalamic amenorrhea (FHA) and suggested that 
restoring adequate nutrition might lead to the resumption of menstrual cycles.  Additional 
evidence (Laughlin et al., 1998) pointed to severely restricted fat intake as being a critical 
factor in neuroendocrine-metabolic abnormalities found in stable weight, nonathletic 
women with FHA who did not meet DSM IV diagnostic criteria for eating disorder.  
Finally, results from two studies of women with FHA and one study of women 
with hypothalamic amenorrhea (HA) suggested that balancing nutritional intake might 
restore gonadotropin hormone secretion.  Restoring adequate nutrition led to the 
resumption of normal menstrual cycles and subsequent successful conception in women 
6 
 
with secondary amenorrhea (Abraham et al., 1990). Also, Couzinet et al. (1999) 
investigated gonadotropin hormonal secretion and biophysiological markers (ferretin, 
leptin, plasma free T3, and other assays) of nutrition in women with FHA and healthy 
controls.  Both groups of women were characterized by normal body mass index (BMI) 
and exercise.  The nutritional markers indicated that mild but extended fat restriction 
interfered with gonadotropin hormone secretion in the women with FHA.  Finally, Miller, 
Parulekar, Schoenfeld, Hubbard, & Grinspoon (1998) examined circulating leptin levels 
in normal weight women with hypothalamic amenorrhea (HA) and matched controls with 
normal menstrual cycles.  The women with HA, unrelated to fat mass, had significantly 
lower fat intake and leptin levels.  Taken together these studies support the importance of 
examining women with FHA and HA for disordered eating.  
Women experiencing depression and anxiety.  Symptoms of depression and 
anxiety could also contribute to unbalanced nutritional intake in women experiencing 
infertility.  The depression and/or anxiety could be determined by multiple factors, such 
as the psychological burden of infertility, the negative sequelae of unbalanced nutritional 
intake, and other situational and biological factors.  For example, dieting in healthy 
volunteers has been associated with lower levels of tryptophan, a metabolite of serotonin 
which is implicated in depression and possibly impaired in satiety (Wolfe, Metzger, & 
Stollar, 1997).  Also, depressive symptoms were found to be more commonly 
experienced by women with infertility than by well women receiving routine health care.  
Domar, Broome, Zuttermeister, Seibel and Friedman (1992) examined women with 
infertility for symptoms of depression and found significantly elevated depression scores 
and two times the prevalence of depression. 
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One of the diagnostic criteria for DSM IV TR (American Psychiatric Association, 
2000) Axis I major depression is excess or lack of appetite characterized by a 5% loss or 
gain of body weight within 1 month.  Women who experience appetite changes during 
periods of anxiety are also at risk for unbalanced nutritional intake (Facchinetti, Fava, 
Fioroni, & Genazzani, 1993).  Therefore, women with infertility who experience 
depression and anxiety warrant assessment for disordered eating symptoms.   
Women experiencing eating disorders.  Women who experience anorexia 
nervosa, bulimia nervosa, and eating disorder not otherwise specified are a high risk 
group psychologically and biologically (Wolfe, 2006).  Women with anorexia nervosa by 
definition weigh less than 85% of their expected weight and have at least 3 consecutive 
months of amenorrhea associated with substantial neuroendocrine and psychological 
imbalance (American Psychiatric Association, 2000).  Also, a large proportion of women 
with bulimia nervosa have amenorrhea and other women with bulimia nervosa 
experience problems with luteinizing hormone secretion (Devlin et al., 1989).  
While in-vitro fertilization can lead to successful conception, women who have 
DSM IV TR (American Psychiatric Association, 2000) Axis I eating disorders have been 
found to have poor pregnancy and postpartum outcomes (Abraham et al., 1990; Franko et 
al., 2001; Lemberg & Phillips, 1989; Little & Lowles, 2000; Mitchell-Gieleghem, 
Mittelstaedt & Bulik, 2002; Morgan, Lacey, & Sedgwick, 1999; Namir, Melman, & 
Yager, 1986; Stewart, Raskin, Garfinkle, MacDonald, & Robinson, 1987).  Moreover, 
Franko et al. recommend more frequent assessment of women experiencing a current or 
past eating disorder to assure successful fertility, pregnancy and postpartum outcomes.   
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Therefore, it is a reasonable goal to ensure adequate physiologic and psychological 
stability in women experiencing eating disorders prior to initiating infertility intervention. 
Women with Polycystic Ovary Syndrome.  Problems with infertility, menstrual 
irregularity typical of anovulation, and androgen excess most frequently lead women 
experiencing polycystic ovary syndrome (PCOS) to seek medical evaluation.  
Additionally, a pattern of androgenic fat distribution, insulin resistance and elevated 
leptin levels in obese women with PCOS (Ertuck et al., 2004; Sepilian, Crochet, & 
Nagamani, 2006) warrants examination for disordered eating symptoms in women 
experiencing this complex disorder. 
 The observational and biobehavioral research outcomes discussed above implicate 
disordered eating symptoms as potentially having a role in infertility.  These outcomes 
suggest that women with ovulatory and unexplained infertility could report greater levels 
of disordered eating symptoms when compared with women receiving routine health care 
from their PCP.  Further study of women with ovulatory and unexplained infertility for 
eating disordered symptoms was warranted using a large sample and carefully controlled 
research design.     
Purpose of the Study and Research Questions 
 The overall goal of this descriptive, comparative study was to investigate 
disordered eating symptoms in women with ovulatory and unexplained infertility in 
comparison to a group of women receiving routine health care from their PCP.  The study 
answered the following research questions through testing the stated hypotheses: 
Research Question 1:  Do women with ovulatory and unexplained infertility significantly 
differ from women receiving routine health care from their PCP in disordered eating 
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symptoms as measured by the Eating Disorder Inventory-3-Referral Form (EDI-3-RF; 
Garner, 2004) and Eating Disorder Risk Composite subscale raw scores? 
Hypothesis 1:  After controlling for selected variables (age, education, income, 
marital status, work status, race and current BMI), women experiencing ovulatory 
and unexplained infertility will report significantly more disordered eating 
symptoms than women receiving routine health care from their PCP. 
Research Question 2:  Do women with ovulatory and unexplained infertility significantly 
differ from women receiving routine health care from their PCP in meeting DSM IV TR 
(American Psychiatric Association, 2000) Axis I eating disorder criteria using participant 
responses on the Eating Disorder Inventory-3-Symptom Checklist (EDI-3-SC; Garner, 
2004)? 
Hypothesis 2a:  Women experiencing ovulatory and unexplained infertility will 
report significantly more current DSM IV TR (American Psychiatric Association, 
2000) Axis I eating disorders than women receiving routine health care from their 
PCP. 
Hypothesis 2b: Women experiencing ovulatory and unexplained infertility will 
report significantly more past DSM IV TR (American Psychiatric Association, 
2000) Axis I eating disorders than women receiving routine health care from their 
PCP.   
Research Question 3: Do women with ovulatory and unexplained infertility significantly 
differ from women receiving routine health care from their PCP in symptoms of 
depression, anxiety, and dietary restraint as measured by participants’ total scores on the 
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Beck Depression Inventory II (Beck, Steer & Brown 1996), the State - Trait Anxiety 
Inventory (Speilberger, 1989) and the Restraint Scale (Herman & Polivy,1980). 
Hypothesis 3:  After controlling for selected variables (age, education, income, 
marital status, work status, race and current BMI), women experiencing ovulatory 
and unexplained infertility will report significantly more symptoms of depression, 
anxiety, and dietary restraint than women receiving routine health care from their 
PCP.  
Definitions 
Infertility.  Infertility is defined as the inability to become pregnant despite 
efforts to conceive for 1 year duration (Stephen & Chandra, 1998).  Etiologic factors 
involved in infertility include ovulation disorders, tubal disease, endometriosis and 
unexplained infertility.  These factors can co-occur or occur with male factors.  Research 
outcomes indicate that women with ovulation problems or unexplained infertility may 
have disordered eating symptoms, and thus, women with infertility that have ovulation 
and explained infertility will be examined and compared with women receiving routine 
health care from their PCP.  The presence of ovulatory or unexplained infertility was 
determined by the self-report of women who self-refer to the study. 
Ovulatory infertility.  Infertility related to problems developing oocytes  
is termed ovulatory infertility.  Ovarian function is evaluated by FSH, LH, estradiol (E) 
and other hormonal tests.  Ovulatory dysfunction can be present in women who 
experience menstrual cycles < 22 days (polymenorrhea), > 35 days (oligomenorrhea), or 
no menses (amenorrhea). Poly Cystic Ovary Syndrome (PCOS) (estimated occurrence 
70%) (Knochenhauser et al., 1998), hypothalamic amenorrhea (10%), hyperprolactinemia 
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(10%), and premature ovarian failure (10%) are the most frequent etiologies of ovulatory 
dysfunction (Barbeiri, 2002).  
Unexplained infertility. Unexplained infertility is diagnosed when a woman is 
having difficulty conceiving and her diagnostic infertility tests (semen analysis, tests of 
ovulation, hormonal profile, uterus and tubal patency) are all normal.  Unexplained 
infertility may represent a problem of having a subthreshold case of one of the infertility 
diagnoses where the infertility tests remain within the normal range (Templeton, 2000). 
Exercise.  Exercise is defined as the exertion of the muscles or limbs for purpose 
of strength, health, and/or weight management.  Descriptive information on exercise was 
characterized by participant’s responses to the exercise questions on the EDI-3-SC 
(Garner, 2004). 
Body Mass Index.  BMI is a measure of body fat that is the ratio of the weight of 
the body in kilograms to the square of its height in meters (Gallagher, et al., 2000).  BMI 
is a reliable indicator of total body fat, which is related to the risk of disease and death.  
BMI categories include: <18.5 indicates an underweight condition, 18.5 to 24.9 is 
considered healthy, 25.0 to 29.9 is considered overweight, 30 to 39.9 indicates obesity, 
and over 40 is considered morbidly obese (Janssen, Katzmarzyk, & Ross, 2002).  Body 
Mass Index was calculated from information reported by study participants on the EDI-3-
RF (Garner, 2004). 
Menstrual Status.   Menstrual status describes the temporal characteristic of 
women’s monthly sexual cycles. These characteristics are normal menstrual cycles, 
oligomenorrhea, and amenorrhea. Menstrual status was operationalized by participants’ 
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report on the Eating Disorder Inventory-3 Symptom Checklist (EDI-3 SC; Garner, 2004) 
using the following parameters: 
Normal menstrual cycles.  Normal menstrual cycles are defined as monthly 
cycles occurring in the range of every 21 – 35 days (Griffin & Ojeda, 1996). 
Oligomenorrhea.  Oligomenorrhea is defined as menstrual cycles occurring > 35 
days.  
Amenorrhea.  Amenorrhea is defined as the failure of menarche by age 16 
(primary amenorrhea) or the cessation of menses for >3 months in a woman with 
a history of periodic menstruation (secondary amenorrhea) (American Psychiatric 
Association, 2000; Burch, 1994; Griffin & Ojeda, 1996).  
Depressive Symptoms.  Depressive symptoms include feelings of sadness, 
pessimism, and failure, punishment and guilt feelings, loss of interest and pleasure, self-
dislike and self criticalness, feelings of worthlessness, suicidal thoughts, crying, agitation, 
irritability, indecisiveness, changes in appetite and sleep, concentration problem, loss of 
energy, tiredness and fatigue, and loss of interest in sex.  Depressive symptoms, a 
potential psychological influence on disordered eating, were measured by participants’ 
total scores on the Beck Depression Inventory-II (BDI-II; Beck, & Steer, 1987). 
Anxiety Symptoms.  Anxiety symptoms comprise an uncomfortable emotional 
state distinguished by personal feelings of pressure or strain, trepidation, apprehension 
and worry and by autonomic nervous system arousal.  Anxiety may be transitory (state) 
or more enduring where it influences and individual’s disposition and reactivity to stress 
(trait).  Anxiety symptoms was measured by participants’ total scores for the separate 
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State (S) and Trait (T) scales on the Speilberger State – Trait Anxiety Inventory 
(Spielberger, 1989).   
State anxiety.  State (S) anxiety refers to an obvious uncomfortable emotional 
reaction taking place at a given time and place.  
Trait anxiety.  Trait (T) anxiety refers to long-term anxiety traits such as long - 
term negative self appraisal.  Trait anxiety addresses unvarying differences in an 
individual’s anxiety proneness and tendency to identify stressful circumstances as 
intimidating.  The individual tends to respond to the stressful circumstances with 
elevations in their state anxiety.  The concept of trait anxiety also addresses the 
individual’s past experience with anxiety and the likelihood that state anxiety will be 
experienced in the future. 
Disordered Eating Symptoms.  Disordered eating symptoms are characterized 
by perceptions, alterations in food ingestion and/or compensatory behaviors intended to 
manipulate body weight and/or shape, which significantly impair health and 
psychological functioning, and are not better accounted for by diabetes, another medical 
condition (malabsorption syndromes) or another psychiatric illness (Klein & Walsh, 
2004).  Eating disorder symptoms were measured by participant’s raw scores on the 
Eating Disorder Inventoy-3-RF subscales of the Eating Disorder Risk Composite 
(Garner, 2004).   
Eating disorder diagnoses.  Eating disorder diagnoses were determined by 
participant report of specific eating symptoms on the EDI-3- SC and other selected scale 
items. Eating disorder diagnosis was assessed by the Principal Investigator transcribing 
information from the ECI-3-SC and selected other items from the ED scales to the SCID 
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Module H along with the DSM IV TR (American Psychiatric Association, 2000) manual 
EDNOS criteria Axis I diagnostic criteria and rated 0 = no diagnosis and 1 = meets 
diagnostic criteria for a diagnosis.  Diagnostic criteria are described for the following 
eating disorder syndromes: Anorexia Nervosa, Bulimia Nervosa, Eating Disorder Not 
Otherwise Specified and the provisional diagnosis for further investigation, Binge Eating 
Disorder.  The eating disorder diagnostic criteria below were adapted from the DSM IV 
TR (American Psychiatric Association, 2000).  Participants can meet only one diagnosis 
currently, although, may have met criteria for a different diagnosis in the past.   
Anorexia nervosa.  The diagnostic criteria for Anorexia Nervosa includes the 
following: (A) Refusal to maintain a body weight or weight loss below 85% of expected 
body weight; (B) intense fear of being fat is expressed despite having an underweight 
condition; (C) disturbance in how one’s body is perceived, excessive influence of weight 
or shape on self-assessment, or rejection of the gravity of the low weight condition; and 
(D) amenorrhea of 3 months or more duration.  Restricting or binge-eating/purging type 
must be distinguished.  
Bulimia nervosa.  The diagnostic criteria for Bulimia Nervosa includes the 
following: (A) Recurring episodes of binge eating depicted by (1) eating a large amount 
(more than most people could ingest) of food within a 2 hour period and (2) experiencing 
a lack of control of the eating episode; (B) engaging in compensatory behaviors to 
assuage weight gain, which could include purging behavior (vomiting, laxatives, other 
medication) or extreme exercise; (C) the binges and behavior to recompense the effect of 
the binges both take place at least two times a week over a temporal period of three 
months or more; (D) self-perception is disproportionately biased by weight and shape; 
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and (E) the disturbance does not take place during an occurrence of Anorexia Nervosa.  
The type of episode must be distinguished by purging or nonpurging. 
  Eating disorder not otherwise specified. This diagnostic category is for eating 
symptoms that suggest the person has an eating disorder that does not meet criteria for 
the eating disorders described above.  Exemplars include: (1) individuals who meet 
criteria for anorexia nervosa except that the they menstruate regularly, (2) individuals 
who meet all criteria for anorexia nervosa, except they maintain their weight above 85% 
IBW, (3) individuals who meet criteria for bulimia nervosa, except the binges and 
compensatory behaviors occur less than two times a week or for less than 3 months 
duration, (4) the compensatory behaviors occur after ingesting small amounts of food and 
binges are not evident, and (5) binges occur but the individual does not swallow the food 
and, instead, spits it out, and (6) binge eating without regular compensatory behavior. 
Binge eating disorder.  The criteria for Binge Eating Disorder are provided in the 
DSM TR IV (American Psychiatric Association, 2000) for further study.  The criteria are 
as follows:  (A) Recurrent binge episodes where a disproportionate amount of food is 
ingested in a short period (2 hours) of time with a loss of control over the amount and 
type of food; (B) three or more characteristics of eating are present; (1) eating more 
rapidly than normal, (2) eating despite discomfort from fullness, (3) eating large amounts 
despite lack of physical experience of hunger, (4) eating in isolation to hide shame about 
one’s large intake, and (5) experience of self-disgust and guilt after eating; (C) distress 
about the binge eating; (D) binges occur 2 days a week for 6 months; and (E) 
compensatory behaviors are not regularly used to offset binges. 
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Dietary Restraint.  Dietary Restraint describes cognitive control of eating 
behavior in individuals who have an enduring focus on dieting.  Restrained eating 
contributes to disinhibited eating behavior (Polivy & Herman, 1985).  Research indicated 
that dieting behavior was clarified to consist of periods of restraint counterbalanced by 
periods of disinhibited eating.  Dietary restraint, a possible influence on disordered eating 
symptoms, was measured by participants’ total scores on the Herman and Polivy (1980) 
Restraint Scale.        
Significance 
This study aims to determine if disordered eating symptoms are increased in 
women with ovulatory and unexplained infertility in comparison with a sample of women 
receiving routine health care from their PCP.  Inquiry in this area might provide 
important knowledge to inform the assessment process of nurses who assess and counsel 
women with infertility and inform the assessment and treatment of women with eating 
disorders by advanced practice psychiatric nurses.  Finding a significant difference in the 
proposed study would provide a foundation to later pursue biobehavioral nursing research 
of women with ovulatory or unexplained infertility.  
Assumptions 
The self-report tools assessing eating disorder symptoms, menstrual function, 
exercise, psychological symptoms, and dietary restraint have been psychometrically 
validated and utilized extensively in clinical trials.  It is assumed that the women will fill 
out the self-report measures honestly. 
Studies show that leptin, a metabolic hormone, has an important role in 
reproductive functioning.  In this study it is assumed that leptin is a candidate link 
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between energy balance and reproductive functioning (ovarian functioning and 
endometrial implantation).   
Limitations 
 Limitations of the proposed study include its descriptive, cross-sectional design 
and use of a non-random sample.  However, while obtaining a single assessment in time, 
the proposed study advances current knowledge by utilizing a larger sample than 





Review of the Literature 
Chapter Two begins with conceptual framework and model for the proposed 
study. Normal female hormonal function is next reviewed. Areas of the literature related 
to infertility, energy balance, and disordered eating symptoms are examined. Ovulatory 
and unexplained infertility is reviewed along with studies at reproductive clinics 
suggesting the influence of disordered eating.  Review of the role of the adipocyte-
derived hormone, leptin, on hypothalamic-pituitary-gonadal (HPG) axis functioning 
provides a possible physiological link between disordered eating symptoms and ovulatory 
and unexplained infertility. 
Conceptual Framework and Model for the Proposed Study 
The conceptual framework (Figure 1) provides additional scientific support to 
pursue research on disordered eating symptoms in women with infertility.  The 
framework contains the investigator’s synthesis of normal female hormone functioning, 
the metabolic fuel hypothesis proposed by Wade, Schneider, and Li (1996) and the 
developing scientific knowledge of leptin, a hormone marker of energy availability and 
balance, that has a role in reproduction (Moschos, Chan & Mantzoros, 2002; Schneider, 
Zhou, & Blum, 2000).  Within the conceptual framework, neuroendocrine (hypothalamic 
and pituitary hormone) control of reproductive physiologic processes (development of the 
ovarian follicle and the endometruim for implantation) is extremely sensitive to energy 







Conceptual Synthesis of Wade’s Metabolic Fuel Hypothesis and Leptin’s Effect on 
 the Female Hormone System and Fertility 





















       Steroidogenesis 







       Endometrium & 
 implantation
   
             
 
Metabolic Fuel Hypothesis.  Wade et al. (1996) posited that reproductive 
physiologic function responds to short-term fluctuations of metabolic fuel availability. 
Examining both comparative and human studies of the effect of metabolic manipulation 
on reproduction, the authors emphasize the vital importance of having a “balance 
between energy intake and expenditure” (p. E6) rather than requiring a fixed level of 
either one.  Momentary to hourly energetic changes in intracellular metabolic fuel 
availability and oxidation (rather than energy reserves alone) are relayed by secondary 
metabolic cues, such as leptin, through neural pathways and neurotransmitters to 
forebrain effector neurons that regulate hypothalamic GnRH emission.  The metabolic 
fuel hypothesis explains the multiple causes of nutritional infertility, for example, lack of 
adequate food, extreme exercise, eating disorders, lacatation, certain kinds of obesity, and 
poorly controlled diabetes mellitus.  Wade et al. (1996) also identified potential promise 




Since Wade et al. (1996) advanced the metabolic fuel hypothesis, outcomes of  
studies have supported that conditions associated with suboptimal nutritional intake and 
conditions with excess energy reserves may negatively affect reproductive outcomes 
(Moschos et al., 2002).  Many of the studies focus on the role of leptin as a marker of the 
adequacy of energy resources and a critical substance for a number of physiologic 
processes, including reproduction.  Suboptimal nutrition was associated with decreased 
serum leptin levels in women experiencing eating disorders (Considine et al., 1996; 
Jimerson et al., 2000; Monteleone, Fabrazzo, Tortorella, Fuschino, & Maj, 2002), 
amenorrhea related to extreme exercise (Landt et al., 1997) and decreased hypothalamic 
function (Miller et al., 1998).  
Excess energy reserves and metabolic problems, such as found in obesity and 
polycystic ovary syndrome (Pasquali & Gambineri, 2006), has been associated with 
elevated serum leptin levels and possible leptin resistance (Moschos et al., 2002).  The 
Moschos et al. understanding of leptin raises the question of whether or not a critical 
level of short-term metabolic fuel availability balanced with energy reserves is required 
for successful reproductive physiologic processes.  Reserves above a critical level may 
negatively influence reproduction through possible leptin resistance. 
Leptin as a link between energy balance and reproduction.  Food intake leads 
to oxidizable metabolic fuel. Short-term fuel availability, energy stores and exercise 
determine energy balance. Overall energy balance indirectly influences leptin secretion 
(Cioffe et al., 1997) through a yet to be identified intracellular primary metabolic signal 
(Schneider et al., 2000).  Leptin acts as a cue between the primary metabolic signal and 
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reproduction (Chehab, Qui, Mounzih, Ewart-Toland & Ogus, 2002; Schneider et al., 
2000).    
Leptin has a stimulatory effect on the hypothalamic-pituitary-gonadal (HPG) axis. 
It acts in concert with other neuroactive substances on the hypothalamus and GnRH 
secretion and directly on pituitary gonadotropes responsible for follicular stimulating 
hormone (FSH) and luteinizing hormone (LH) (Moschos et al., 2002).  Leptin also 
directly affects both the granulosa cells in the ovary and the uterine endometrium. 
Therefore, low levels of leptin detected in states of suboptimal nutrition affect sex steroid 
(estradiol and progesterone) production by the granulosa cells in the ovarian follicle via 
leptin’s reduced effect on LH and to a minor degree FSH secretion and by a direct effect 
on leptin receptors in the granulosa cells that develop into follicles (the female hormonal 
system is discussed below). 
 Excess leptin has a direct inhibitory effect on ovulation through restraining 
estradiol production.  The lower estradiol secretion decreases the elaboration of the 
granulosa cells, the development of the theca interna, and oocyte maturation.  Therefore, 
high leptin levels found in obesity have been associated with problems in follicular 
maturation and anovulatory cycles (Mochos et al., 2002).  
The Wade et al. (1996) metabolic fuel hypothesis and the understanding of leptin 
as a critical substance involved in reproductive physiologic processes provide an initial 
























Figure 2  
Conceptual Model for the Proposed Study
 
Figure 2 contains the conceptual model for the proposed study.  While the focus 
of the framework has been on the metabolic link to neuroendocrine processes (Wade, 
Schneider, & Li, 1996; Wade, 1998), the conceptual model for the proposed study 
recognizes that multiple etiologies, including psychological, cultural, social, and 
biological factors, may contribute to disordered eating symptoms.  The proposed study 
investigates disordered eating symptoms in women with ovulatory and unexplained 
infertility and women receiving routine health care from their PCP and examines the 
continuum of occult disordered eating symptoms through the DSM IV TR (American 
Psychiatric Association, 2000) Axis I eating disorders.   
Normal female hormonal function.  Monthly rhythmical alterations in the rates 
of female hormone release and corresponding changes in the ovaries and other sexual 
organs characterize the normal reproductive years of women.  The regular pattern is 
referred to as the female monthly sexual cycle (Guyton & Hall, 2006).  The average 
duration of the cycle is 28 days. Cycles could occur as short as 20 days or as long as 45 
days; although, decreased fertility has been associated with abnormal cycle length 
(Speroff & Fritz, 2005).  The female sexual cycle is set to produce two important 
outcomes: the maturation of a single ovum each month, so that one fetus will grow at a 
time, and the preparation of the uterine endometrium for successful implantation of a 
fertilized ovum (Tortora & Derrickson, 2006).  
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 The female hormonal system is made up of three hierarchies of hormones: (1) 
gonadotropin-releasing hormone (GnRH) secreted from the hypothalamus; (2) follicular-
stimulating hormone (FSH) and luteinizing hormone (LH), anterior pituitary sex 
hormones secreted in response to GnRH secretion by the hypothalamus; and (3) estrogen 
and progesterone, ovarian hormones secreted in response to FSH and LH by the anterior 
pituitary (Figure 1) (Guyton & Hall, 2006).  Secretion of hypothalamic and pituitary 
hormones varies at different rates or pulses at different times of the monthly cycle.  The 
hormonal pulses vary throughout the proliferative and secretory phases of the monthly 
cycle.  GnRH secretion increases and decreases less drastically during the monthly cycle 
in short pulses every 90 minutes (Porterfield, 2001).  FSH and LH are secreted in a 
pulsatile fashion at different amounts during different times of the cycle.  Both FSH and 
LH stimulate their ovarian target cells through combining with their respective highly 
specific receptors in the ovarian target membranes (Guyton & Hall, 2006).  The activated 
receptors in turn increase the cells’ rates of secretion, growth and proliferation through 
activation of the second messenger system causing the formation of key enzymes that 
simulate sex hormone synthesis (estrogen and progesterone) (Guyton & Hall, 2006). 
Effect of the pituitary hormones on sex hormone synthesis.  During the first few 
days of the monthly female sexual cycle, the FSH and LH concentrations are to some 
extent increased, with FSH being slightly greater and earlier than LH by a couple of days 
(Guyton & Hall, 2006; Porterfield, 2001; Tortora & Derrickson, 2006).  These hormones, 
especially FSH, enhance the growth of 6 to 12 primary ovarian follicles each month.  The 
initial effect leads to rapid production and elaboration of ovarian granulosa cells 
(Porterfield, 2001).  First, a second mass of cells develops called the theca.  The theca 
24 
 
then divides into two layers, the theca interna, which develops the ability to secrete 
additional estrogen and progesterone, and the theca externa which develops very vascular 
connective tissue that becomes the exterior of the developing follicle (Guyton & Hall, 
2006).  In addition to stimulating follicular growth, estrogen also stimulates proliferation 
of endometrium (Porterfield, 2001).  
After the initial growth, the mass of granulosa cells secretes a follicular fluid with 
a high concentration of estrogen.  Positive feedback loops lead to both greater FSH 
sensitivity and greater estrogen secretion.  The FSH and the estrogens combine to 
promote the development of LH receptors creating a more rapid increase in follicular 
secretion leading to explosive growth of the follicles (Guyton & Hall, 2006; Tortora & 
Derrickson, 2006). 
After a week of growth, but before ovulation, one follicle outgrows the others and 
the other follicles involute and become atretic.  The large amount of estrogen expressed 
from the follicle depresses FSH output from the pituitary, which blocks the growth of less 
developed follicles.  The process of atresia generally allows for only one follicle to reach 
full maturation (Guyton & Hall, 2006; Tortora & Derrickson, 2006).  
Two days prior to ovulation, LH secretion by the anterior pituitary increases 6 to 
10 fold while FSH increases 2 to 3 fold. The prolonged excessive estrogen secretion 
ceases one day prior to ovulation (Tortorta & Derrickson, 2006).  LH is critical for final 
follicular growth and ovulation.  After ovulation, the granulosa cells become the corpus 
luteum (Porterfield, 2001) and progesterone secretion from the corpus luteum increases.  
The pituitary hormones act synergistically to cause rapid swelling of the follicle, and LH 
affects the theca and granulosa cells converting them to progesterone–secreting cells 
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(Guyton & Hall, 2006).  Progesterone prepares the secretory endometrium in the uterus 
for implantation and develops the alveolar tissue of the breast (Porterfield, 2001). 
In summary, a complex process within the hypothalamus-pituitary-gonadal (HPG) 
axis is responsible for the development of ovarian follicles and the preparation of the 
uterine endometrium for implantation of the ova.  Since only 20% of fertile couples will 
conceive in a cycle (Speroff & Fritz, 2005), it is presumed that fluctuations within HPG 
hormonal axis, associated physiological processes, and other female and male factors 
explain the low percent of conception per cycle.  
Infertility 
 
 The NSFG (2002) estimated a 7.4% incidence of infertility in women aged 15 to 
44 years.  Ovulatory dysfunction, tubal and peritoneal pathology, male factors, infertility 
unexplained by diagnostic tests, and less commonly occurring uterine factors are the 
major causes of infertility (Speroff & Fritz, 2005).  Speroff and Fritz (2005) identify 
central factors of the reproductive process requiring evaluation are male factors, ovarian 
factors, cervical factors, tubal factors and uterine factors.  Infertility evaluation is aimed 
at isolating and examining the components of the human reproductive process as well as 
discovering problems that could possibly interfere with conception. Since previously 
insoluble infertility difficulties can now be bypassed by assisted reproductive 
technologies (ART), the speed and scope of the evaluation are determined by the couple’s 
desires, length of infertility, and individual particularities of the medical history and 
physical examination (Collins et al., 1993).  Because time is of the essence for the 
infertile couple, less emphasis is situated on determining a precise diagnosis than on 
implementing the most efficacious and cost-effective treatment (Speroff & Fritz, 2005). 
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Ovulatory dysfunction.  Twenty-five percent of women experiencing infertility 
have ovulatory problems (Imani et al., 2002).  Menstrual cycles between 22 and 35 days, 
accompanied by bloating, dysmenorrhea, and breast sensitivity imply that ovulation is 
occurring.  Ovulatory dysfunction can be present in women who experience menstrual 
cycles < 22 days (polymenorrhea), cycles > 35 days (oligomenorrhea), or no cycles 
(amenorrhea).  Polycystic ovary syndrome (PCOS; estimated occurrence of 70% of 
women with ovulatory problems; Knochenhauser et al., 1998), hypothalamic amenorrhea 
(10%), hyperprolactinemia (10%), and premature ovarian failure (10%) are the most 
frequent etiologies of ovulatory dysfunction (Barbieri, 2002).  
Polycystic ovary syndrome is characterized as the occurrence of oligoamenorrhea 
or amenorrhea and hyperandrogenism without evidence of other hyperandrogenic 
disorders.  Polycystic ovary syndrome is also considered a metabolic disorder due to the 
co-occurrence of symptoms indicative of syndrome X (Linne, 2004).  Hypothalamic 
(HA) amenorrhea is a diagnosis of exclusion (Speroff & Fritz, 2005).  Regarded as a 
central nervous system disorder, hypothalamic amenorrhea generally is suggested by low 
levels of GnRH emission, withdrawal bleeding only in response to progestational 
challenge, and low or normal levels of LH and FSH with normal prolactin and thyroid 
stimulating hormone levels (Barbieri, 2002; Speroff & Fritz, 2005).  Hyperprolactinemia 
with prolactin level greater than100 ng/ml requires Magnetic Resonance Imaging (MRI) 
for a pituitary secreting adenoma; although, Speroff & Fritz (2005) caution that 
microadenoma was found in up to 27% of people in an autopsy series.  Premature ovarian 
failure occurs in 1% of women prior to the age of 40, and women experiencing primary 
amenorrhea have a 10% to 28% incidence of premature ovarian failure.  Women with 
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premature ovarian failure have withdrawal bleeding from progestational challenge but 
have high gonadotropin levels (Speroff & Fritz, 2005).  
Unexplained infertility.  When semen analysis, tests of ovulation, uterus and 
tubal patency are normal, unexplained infertility is diagnosed (Templeton, 2000).  This 
diagnosis represents the lower extreme of normal reproductive efficiency and limitations 
of the knowledge of the fertilization process (Collins & Crosignani, 1992; Speroff & 
Fritz, 2005)).   
A lesser understood condition thought to occur in some women with unexplained 
infertility is luteal phase deficiency.  Luteal phase deficiency addresses cases of infertility 
along the continuum between fertility and infertility, is thought to be responsible for 
cases of subfertility, and may explain some cases of unexplained infertility (Collins & 
Crosignani, 1992).  This is a speculative disorder where ovulation occurs, but the corpus 
luteum produces levels of progesterone insufficient to support successful implantation 
(American College of Obstetrics & Gynecology Practice Bulletin, 2002).  The lack of 
controlled trials with women with established fertility renders luteal phase deficiency 
more of a putative condition than a clear cut disorder. 
Another condition that could have a role in unexplained infertility is minimal and 
mild endometriosis (Speroff & Fritz, 2005).  While it is clear that advanced stage 
endometriosis with endometriomas and adhesions can greatly impair fertility, the effect 
of mild endometriosis is less understood.  Similarly, subthreshold difficulties with 
characteristics of the semen, the uterus, or fallopian tube patency may be better 
understood in the future.  
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 Ovulatory dysfunction can preclude conception (anovulation) or be a contributory 
factor (oligoovulation).  However, it must be again noted that only 20% of fertile couples 
will conceive in a cycle (Speroff & Fritz, 2005); and thus, a diagnosis of ovulatory 
problems can change over time. 
Studies Conducted at Reproductive Clinics 
 Research outcomes of studies conducted at reproductive clinics revealed a 
potential link between the altered nutritional intake associated with disordered eating 
symptoms and the ovulation disorders of infertility.  Bates et al. (1982) examined the 
effect of weight control on menstrual cycles, serum FSH and LH, and infertility, as well 
as the effect of weight restoration on reproduction.  The sample was comprised of 29 
women with unexplained infertility (93% with menstrual irregularity) and 18 women 
referred due to menstrual irregularity but seeking to conceive.  Participants were 
interviewed regarding menstrual history and cycle characteristics, pregnancies, maximum 
body weight and weight control practices, and physical activity.  Serum gonadotropins 
were measured.  Luteinizing hormone and FSH were related to ideal body weight. 
Nineteen of the 26 women experiencing infertility spontaneously conceived with weight 
gain.  The outcomes suggested that luteal phase deficiency may be associated with 
dieting behavior, and thus, dieting behavior may be an unrecognized etiology of 
reproductive problems. 
 Stewart et al. (1990) prospectively assessed 66 consecutive women with infertility 
at a university reproductive service.  The Eating Attitude Test (EAT) was administered 
and participants were questioned regarding current and historical weight, menstrual 
history, and gynecologic history.  Participants scoring > 20 on the EAT were interviewed 
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for DSM III (American Psychiatric Association, 1983) diagnosis of an eating disorder. 
Eleven women (7.6%) were identified as having an eating disorder.  When eating 
disorders not otherwise specified EDNOS was included, 16.7% of the women had an 
eating disorder.  Eating Attitude Test scores were significantly elevated (p < 0.0001) in 
women with menstrual irregularity. Fifty-eight percent (58%) of the women with 
infertility who had amenorrhea or oligomenorrhea had eating disorders.  Stewart et al.  
highlight the elevated rate of eating disorders in their participants from the reproductive 
clinic.  The rate in their study was 2 to 4 times the rate predicted by population studies.  
None of the women with an eating disorder in the Stewart et al. study informed their 
physician of their disordered eating symptoms. 
 Abraham et al. (1990) examined the eating and exercise histories of 14 women 
with secondary amenorrhea who were being treated with GnRH after failing Clomid 
treatment at an infertility clinic.  Participants were interviewed for changes in weight, 
exercise, and eating behaviors, menstrual history, and past physical or psychiatric illness. 
The EAT and Eating Disorder Inventory were administered and weight, height and body 
fat were measured.  Thirteen of the women met diagnostic criteria for eating disorders.  
Two women were previously diagnosed with depression.  Five of the participants were 
currently diagnosed with eating disorder not otherwise specified, and two women were 
compulsive exercisers.  Abraham et al. suggested assessing and treating disordered eating 
and exercise behavior prior to initiating infertility drugs to induce ovulation because of 
the risk for negative pregnancy outcomes.   
 Results from the studies discussed above revealed a potential link between 
disordered eating symptoms and ovulation disorders and unexplained infertility.  A 
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methodological limitation of these early studies was small sample size and lack of 
adequate power. The studies were also limited by lack of a comparison group.  Finally, 
Bates et al. (1982) did not systematically investigate disordered eating symptoms. 
 Later research involved investigations in weight stable women with functional 
hypothalamic amenorrhea (FHA) and comparison groups.  Marcus, Loucks and Berga 
(2001) examined 77 women with amenorrhea (28 with FHA, 18 with primary ovarian 
failure since menarche, 24 with organic amenorrhea, and 25 healthy volunteers.  
Participants with DSM IV TR (American Psychiatric Association, 2000) disorders were 
excluded using the Structured Clinical Interview for the Diagnostic and Statistical 
Manual IV (SCID; Spitzer, Williams, Gibbon, & First, 1992).  The Eating Disorder 
Inventory-2 (EDI-2; Garner, 1991) was administered. Women with FHA reported more 
dieting and weight concerns, subclinical binges, and apprehension of weigh gain.  
Women experiencing FHA also demonstrated more characteristics associated with eating 
disorders such as, perfectionism and concern regarding judgment by others.  
Couzinet et al. (1999) assessed 12 women experiencing functional hypothalamic 
amenorrhea with normal BMI and exercise activity with 12 age and BMI matched 
healthy volunteers and 6 women with congenital hypothalamic hypogonadism for 
comparison of GnRH secretion and possible reversible nutritional contribution.  Selected 
pituitary and gonadal hormones, the GnRH agonist test, dietary intake, body composition, 
and nutritional markers (ferretin, TSH, leptin and other assays) were assessed.  Women 
with functional hypothalamic amenorrhea consumed significantly less fat than the healthy 
volunteers; and nutritional markers, including leptin, were significantly decreased.  
Couzinet et al. (1999) determined mild dieting with extended fat restriction was able to 
31 
 
interfere with gonadotropin emission.  The researchers recommended assessment of 
nutritional markers to identify mild nutritional deficits as a possible reversible etiology of 
functional hypothalamic amenorrhea.  
    Verri et al. (1998) studied the relationship between secondary amenorrhea, due 
to hypogonadotropic, hyperandrogenic, and hyperprolactinemic etiologies, eating 
disorders and psychiatric comorbidity.  None of the participants, recruited from the 
reproductive clinic, were seeking help for infertility.  Modules of the SCID (Spitzer, 
Williams, Gibbon, M., & First, 1992) assessed mood, anxiety and eating disorders.  
Eating disorders were significantly increased in women with hypogonadotropic 
amenorrhea.  Also, 40.9% of women with hyperandrogenic amenorrhea had eating 
disorders.  Women experiencing eating disorders had a high incidence of psychiatric 
comorbidity; however, women who did not have eating disorders demonstrated a similar 
trend.  Verri et al. (1998) questioned what comes first, hormonal dysfunction versus 
psychiatric problems. 
In summary, more recent studies using control groups underscore potential 
nutritional etiologies in women with secondary amenorrhea.  Women with 
hyperandrogenic amenorrhea also had eating disorders.  The nutritional deficits centered 
on fat restriction.  Even when individuals with eating disorders were excluded, some 
women with functional hypothalamic amenorrhea demonstrated psychological traits 
similar to individuals experiencing eating disorders.  These findings warrant further 




Energy Balance in Women Seeking to Conceive 
Eating a healthy diet composed of a variety of foods is important throughout life.  
However, healthy nutrition is imperative during preconception and pregnancy 
(Williamson, 2006).  Healthy nutrition is important to the production of sex steroid 
hormones (steroidogenesis), the development of the ova (gametogenesis) and 
implantation (Schneider & Wade, 2000).  Nutritional status at the time of conception is 
also essential to fetal growth and development (Williamson, 2006). Williamson (2006) 
identifies that the embryo is at greater risk to the consequences of poor nutrition during 
the very early weeks (3-7 weeks) of development when rapid cell division and 
differentiation occurs.  
Energy Availability.  Reproduction requires greater energy expenditure for 
women than for men (Schneider & Wade, 2000; Wade, 1996; Wade, 1998).  
Reproduction in women ultimately demands an adequate food supply to be able to 
reproduce and, at the same time, maintain other vital homeostatic physiological processes 
such as, cellular continuation, thermoregulation, movement and growth (Wade 1998).  In 
times of negative energy expenditure when food is less available, such as during 
starvation or increased physical energetic demand without increased nutritional intake, 
animals and humans partition their food to those basic processes necessary for survival 
through an adaptive physiological process (European Society of Human Reproduction & 
Embryology Capri Workshop Group, 2006).  Thus, reproduction is suspended until 
conditions optimal to conception are reinstated (Wade, 1998).  
Nutrition intake provides the body with available metabolic fuel for cellular 
continuation, thermoregulation, movement and growth along with higher order processes, 
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such as reproduction (Wade 1998).  Nutritional intake must be sufficient to ensure the 
necessary energy homeostasis for reproduction.  Ellison (2003) describes three elements 
of energy availability and successful conception.  The elements include “energy status, 
energy balance and energy flux” (Ellison, 2004, p. 344).  Energy status includes the 
quantity of stored energy that can be marshaled for reproductive attempt.  Energy balance 
is the remaining energy intake minus energy outflow that likely can be assigned to 
reproduction (Schneider & Wade, 2000).  Energy flux is the actual level of energy 
turnover independent of energy balance.  Ellison (2003) views conception as being 
sensitive to positive energetic conditions, and ovarian function specifically being 
sensitive to energy balance and flux. 
Body Mass Index and Body Fat Distribution in Women Seeking to Conceive. 
Normal body weight does not assure successful fertility outcomes.  Once thought to be 
indicative of healthy nutrition, ideal or average body weight according to the 
Metropolitan Life Tables (Metropolitan Life Insurance Company, 1959) is being replaced 
by BMI (kilograms/meters2) (Flegal, Troiano, & Ballard-Barbash, 2001).  BMI is a better 
indication of energy reserves (Gallagher et al., 2000). BMI of at least 22 rather than 
absolute body weight has been implicated in normal ovulatory function and menstruation 
(Thomas, 2001).  Women who maintain a low body weight associated with eating 
disorders or recurrent dieting often experience irregular menstrual cycles and may 
possibly have a longer trajectory to conception (Goldberg, 2002). Conversely, fertility 
can also decline in women with excessive fat stores.  Healthy women with a BMI > 30 
presenting for a prospective study of infertility treatment by artificial insemination 
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demonstrated a lower pregnancy rate than women with a low BMI (< 20) (Zaadstra et al., 
1993).  Women with a BMI in the range of 20 – 25 had the best pregnancy rate. 
 Zaadstra et al. (1993) also found that body fat distribution is more likely than 
obesity itself to affect fertility.  Increased waist-to-hip ratio was negatively related to 
likelihood of conception.  Body fat distribution as a predictor of fertility was significant 
before and after statistical adjustment for age, obesity, parity, characteristics of menstrual 
cycles and extent of infertility.  
A similar outcome was reported by Kirchengast and Huber (2004) in a study of 15 
women with secondary amenorrhea associated with anorexia nervosa, 16 women with 
polycystic ovary syndrome with secondary amenorrhea or oligomenorrhea, 10 women 
with idiopathic primary amenorrhea and 19 healthy volunteers with regular menstrual 
cycles from an Austrian university clinic.  All groups with amenorrhea were statistically 
different when compared to healthy controls on body fat and bone mineral paramenters 
but not lean body mass.  Women with anorexia nervosa and healthy women demonstrated 
a gyneoid (pear shape) fat distribution, and women with polycystic ovarian syndrome had 
an android (central) distribution.  Thus, Kirchengast and Huber (2004) view body fat 
distribution as an extragenital marker.  
 Women with a low BMI before and during pregnancy are at greater risk of 
delivering low birth weight (LBW) babies with greater risk of morbidity and mortality 
(Institute of Medicine, 1990).  Women who are overweight or obese before and during 
pregnancy are at greater risk of having gestational diabetes, hypertension and pre-
eclampsia (Goldberg, 2002).  Moreover, as BMI increases, the risk of these complications 
also increases (Linne, 2004). 
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 Healthy nutrition is critical for successful reproduction.  Initially, it was believed 
that energy stores were the critical for normal menstrual function and fertility (Frisch, 
1978).   However, energy balance specifically addresses the availability of nutritional 
fuel.   Too little or excess available fuel potentially can negatively influence fertility 
(Moschos et al., 2002). 
Disordered Eating Symptoms 
 Women experience disordered eating symptoms for a variety of reasons.  Women 
can restrict their dietary intake, engage in obvious dieting behaviors, or utilize 
compensatory behaviors to offset weight and food intake.  Reasons for these behaviors 
can include the desire to maintain a slim or athletic body size, symptoms of anxiety 
and/or depression, and the more complex DSM IV TR (American Psychiatric 
Association, 2000) eating disorders.  
Normal weight women with restrictive eating patterns.  Normal weight 
women who achieve a slim body appearance through utilizing restrictive or strict low fat 
diets are at risk for menstrual disorders (Couzinet et al., 1999: Rock, Gorenflo, 
Drewnowski, & Demitrack, 1996b; Warren et al., 1994). Laughlin et al. (1998) 
uncovered evidence of severely restricted dietary fat intake among stable weight, 
nonathletic women with functional hypothalamic amenorrhea.  The women with 
functional hypothalamic amenorrhea and their matched healthy controls did not meet 
DSM IV diagnostic criteria (American Psychiatric Association, 2000) for an eating 
disorder or depression.  The Laughlin et al. subjects were specifically selected for no or 
minimal exercise or weight loss; however, the women with functional hypothalamic 
amenorrhea and restrictive dietary fat intake had neuroendocrine-metabolic abnormalities 
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indicative of a hypometabolic state, similar to what is found in exceedingly trained 
athletes with functional hypothalamic amenorrhea. 
Energy deficiency in women who strenuously exercise.  Strenuous exercise 
without a compensatory increase in calories leads to hypoestrogenism and the related 
physiological consequences of menstrual irregularities, bone loss, and potential 
cardiovascular risk (De Sousa, 2003).  When dietary restraint is coupled with strenuous 
exercise energy expenditure, energy deficiency results; and the body responds with either 
weight loss or energy conservation (down-regulation of metabolism).  Physiological 
response to the energy deficits subsequently affect hypothalamic function and lead to 
suppression of reproductive function (Williams, Helmreich, Parfitt, Caston-Balderrama, 
& Cameron, 2001).  The female athlete triad represents the most extreme case of serious 
energy deficit associated with physical exercise.  The female athlete triad is a syndrome 
in athletes involving disordered eating, amenorrhea, and osteoporosis (Otis, Drinkwater, 
Johnson, Loucks & Wilmore, 1997).   Menstrual cycle irregularities in athletes and in 
recreationally physically active women who restrain their dietary intake have been 
described as existing on a continuum from luteal phase deficiency to amenorrhea (De 
Sousa, 2003; Ellison, 2003).  
 Luteal phase defects exist in athletes and physically active women who restrict 
their dietary intake due to reduced progesterone production during the luteal phase.  In 
essence, the hormonal system functions adequately for ovulation but not for preparation 
of the uterine endometrium for implantation.  Also possible on the continuum of 
reproductive functioning are anovulatory cycles (McConnell, O’Connor, Brindle & 
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Williams, 2002), oligoamenorrhea (Cobb et al., 2003; Loucks & Horvath, 1985) and 
amenorrhea (De Souza, 2003). 
 Morris et al. (2006) prospectively examined exercise histories and reproductive 
outcomes in 2,232 women with infertility prior to their first in vitro fertilization cycle.   
Women who exercised regularly (less than 4 hours a week) were no more likely to have a 
successful birth outcome than women who did not exercise.  However, women who 
exercised 4 hours or more a week were 40% less likely to have a live birth and were three 
times more likely to experience cycle cancellation (inadequate ovarian stimulation with 
oocyte retrieval failed or not performed).  The women who exercised 4 or more hours a 
week were two times as likely to experience implantation failure or pregnancy loss.  
Cardiovascular exercise reduced the likelihood of a live birth by 30%.  The researchers 
concluded that women who engaged in exercise 4 hours or more a week for 1 to 9 years 
were more likely than women who did not exercise to have negative IVF outcomes.       
Women experiencing depression and anxiety.  Women experiencing episodes 
of depression and anxiety could also be at risk for unbalanced nutritional intake. The 
depression and/or anxiety could be determined by multiple factors, such as the 
psychological burden of infertility, the negative sequellae of unbalanced nutritional 
intake, and other situational and biological factors. For example, dieting in healthy 
volunteers has been associated with lower levels of tryptophan, a precursor to serotonin, 
which is implicated in depression and possibly impaired in satiety (Wolfe et al., 1997).  
One of the diagnostic criteria for DSM IV TR (American Psychiatric Association, 
2000) Axis I major depression is excess or lack of appetite characterized by a 5% loss or 
gain of body weight within one month (APA, 2000).  Kalantaridou, Makrigiannakis, 
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Zoumakis, and Chrousos (2004) have proposed that stress, through activating the 
hypothalamic-pituitary-adrenal (HPA) axis, has a restraining effect on reproduction.   
Stress through its effect on the arousal and autonomic nervous systems leads the 
hypothalamus to release corticotropin-releasing hormone (CRH) to stimulate 
adrenocorticotropic hormone (ACTH), which in turn affects cortisol release by the 
adrenal cortex.  When the stress system is activated, reproduction is inhibited through the 
increased CRH secretion (and other related stress hormones), which inhibits GnRH 
emission.  There is less stimulation of pituitary FSH and LH and subsequent estrogen and 
progesterone secretion by the ovary.  This affects ovarian follicle development and 
preparation of the endometrium for implantation.  Kalantaridou et al. (2004) contend that 
these effects explain the stress-related hypothalamic amenorrhea exhibited in women 
experiencing anxiety and depression and women with exercise disorders and eating 
disorders.  Women who experience appetite changes during periods of anxiety are also at 
similar risk for unbalanced nutritional intake (Facchinetti, Fava, Fioroni, & Genazzani, 
1993).  
Domar, Broome, Zuttermeister, Seibel, and Friedman (1992) examined women at 
an infertility clinic and a control group of well women receiving routine health care for 
symptoms of depression and found that women with infertility commonly experience 
depressive symptoms.  The women completed two depression scales and provided 
demographic information.  The women with infertility scored significantly higher on the 
depression scales (Beck depression Inventory p < 0.0003; Center for Epidemiological 
Studies Depression Scale p < 0.0006).  Women with 2 to 3 years of infertility scored the 
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highest.  Also, the women experiencing infertility had twice the prevalence of depression 
when compared with well women receiving routine medical or gynecologic care.  
Women experiencing eating disorders.  Women who experience anorexia 
nervosa, bulimia nervosa, and eating disorder not otherwise specified are a high risk 
group psychologically and biologically.  Women with anorexia nervosa by definition  
weigh 85% of their expected weight and have at least 3 consecutive months of 
amenorrhea associated with substantial neuroendocrine and psychological imbalance 
(American Psychiatric Association, 2000).   Normal or over-weight women with bulimia 
nervosa who utilize binge-purge behaviors or excessive exercise, are another group of 
women at risk for infertility.  
 Eating disorders are distinguished in the DSM IV TR by their cardinal criterion of 
seriously disordered eating symptoms (American Psychiatric Association, 2000).  
Anorexia nervosa and bulimia nervosa are the most extreme of the eating disorder 
syndromes.  Eating disorder not otherwise specified includes aspects of the two main 
disorders or the provisional diagnosis associated with over-eating, binge eating disorder 
(American Psychiatric Association, 2000). 
 Anorexia nervosa.  Anorexia nervosa, an eating disorder first identified in the late 
19th century, is associated with psychiatric syndromes with the greatest mortality rates 
(Harris & Barraclough, 1998).  Anorexia nervosa was studied and treated more 
intensively as a distinct syndrome in the 1970s.  Anorexia nervosa affects women at a 
ratio of 10-20:1, women to men (Klein & Walsh, 2004).  The estimated lifetime 
prevalence of anorexia nervosa among women is 0.5 – 2% (APA, 2000).  Because the 
disorder tends to emerge as the hypothalamic-pituitary-gonadal axis is maturing, Klein 
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and Walsh (2004) question whether or not some individuals demonstrate sensitivity to 
this maturation in the development of an eating disorder.  
Central symptoms of anorexia nervosa include refusal to maintain a normal body 
weight body weight (15% below that expected), intense fear of gaining weight, 
perceptual disturbance in how one’s weight and shape is personally experienced, and 
amenorrhea for three consecutive months (in females postmenarche) (American 
Psychiatric Association, 2000).  Two subtypes of anorexia nervosa have been identified: 
individuals who restrict their food and individuals with binge-eating and purging 
episodes.  Restriction involves severe dieting and fasting (Klein & Walsh, 2004). Purging 
episodes can include abuse of laxatives and diuretics.   
 Bulimia nervosa.  In the late 1970s, bulimia nervosa was introduced by Russell 
(1979); and since its description, the prevalence has exceeded that of anorexia nervosa 
(Klein & Walsh, 2004).  Bulimia nervosa involves repeated binge-eating episodes, 
behaviors to prevent weight gain, and preoccupation with shape and weight in the 
absence of anorexia nervosa (American Psychiatric Association, 2000).  Individuals with 
bulimia nervosa usually have a normal weight for their height.  While the estimated 
lifetime prevalence of bulimia nervosa is 1 – 3% among women, some individuals may 
begin with anorexia nervosa symptoms then move to predominant symptoms of bulimia 
nervosa (American Psychiatric Association, 2000). 
 The binge episodes characteristic of bulimia nervosa entail an intake of an 
unusual amount of food, from 2,000 to 9,000 or more calories, in a short burst of time.  
Binge episodes must occur two or more times a week for a three month time period to 
meet DSM IV TR diagnostic criteria (American Psychiatric Association, 2000).  The two 
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subtypes of bulimia nervosa include purging and non-purging subtypes.  Abuse of 
laxatives and self-induced vomiting compensate for the binges of individuals with the 
purging type of bulimia nervosa.  Extreme duration of exercise, extended fasting, and 
severe dieting compensate for binge episodes in the non-purging subtype.  
Women with bulimia nervosa have also been found to have menstrual 
dysfunction.   Pirke et al. (1987) found at least 50% of women with bulimia nervosa in 
their study suffered from amenorrhea or oligomenorrhea.  Changes in luteinizing 
hormone (LH) secretion can be a problem for some women with bulimia nervosa; 
although, there is currently a debate in infertility circles as to whether altered LH 
secretion poses a true infertility problem (Smith, Pfeifer, & Collins, 2003). 
Individuals with bulimia nervosa more frequently experience comorbid anxiety 
and depression, as well as substance use and personality disorders.  Brewerton et al. 
(1995) found a 75% lifetime prevalence of affective disorders in participants with bulimia 
nervosa in their studies.  
Contrasting anorexia nervosa and bulimia nervosa.  Women with anorexia 
nervosa and bulimia nervosa share some psychological attributes (Klein & Walsh, 2004).   
Concealment of the illness behaviors and shame is common to both groups.  Also shared 
are embarrassment about their weight and body shape, the content of the binge episodes, 
and the severe measures to avert weight gain can obstruct individuals from seeking 
appropriate treatment.  Klein and Walsh noted that women experiencing anorexia nervosa 
can experience an unabating desire to be thin along with lack of recognition of illness, 
two attributes that serve as barriers to seeking psychiatric treatment.  Although, women 
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with bulimia nervosa also tend to avoid treatment until medical sequelae arise.  Anorexia 
nervosa is more refractory to treatment than bulimia nervosa. 
Women with anorexia nervosa have amenorrhea for three months or more, and a 
large proportion of women with bulimia nervosa have amenorrhea, while others 
experience problems with luteinizing hormone secretion (Devlin et al., 1989). Although 
in-vitro fertilization can lead to successful conception, women who have DSM IV TR 
Axis I eating disorders continue to be at higher risk for cesarean section (Franko et al. 
2001; Mitchell-Gieleghem et al., 2002), low birth-weight babies (Abraham et al., 1990), 
postpartum depression (Franko, et al., 2001; Morgan, Lacey, & Sedgwick, 1999), and 
relapse of their eating disorder exacerbated by the expected weight and fat distribution 
issues of the postpartum period (Lemberg & Phillips, 1989; Little & Lowles, 2000; 
Namir et al., 1986; Stewart et al., 1987).  Women with eating disorders are classified as at 
risk and require more frequent assessment to assure successful fertility, pregnancy and 
postpartum outcomes (Franko et al., 2001).  Therefore, it is a reasonable goal to ensure 
adequate physiologic and psychological stability in women experiencing eating disorders 
prior to initiating infertility intervention.   
            Women can exhibit disordered eating symptoms consistent with aspects of DSM 
IV TR (American Psychiatric Association, 2000) eating disorders.  Eating disorder not 
otherwise specified describes with examples eating disorders that do not meet the full 
DSM IV TR diagnostic criteria for a Anorexia Nervosa and Bulimia Nervosa.  For 
example, women that experience all of the diagnostic criteria of anorexia nervosa, except 
menstrual cycles continue to occur, are included under eating disorder not otherwise 
specified diagnostic criteria. 
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Eating disorders not otherwise specified.  Additionally included in the eating 
disorder not otherwise specified diagnosis are individuals who have binge eating 
disorder.  The binge eating disorder set of diagnostic criteria is provisional and provided 
in the DSM IV TR for further research study.  Individuals with binge eating disorder may 
be genetically predisposed to weigh more than the cultural ideal, which currently is 
unrealistic (American Psychiatric Association, 2000). 
Individuals experiencing binge eating disorder describe episodes of ingesting 
large quantities of food in a short discrete period of time, but they do not exhibit 
compensatory behaviors commonly seen in women with bulimia nervosa.  Women with 
binge eating disorder do not regularly vomit, over-exercise, or abuse laxatives or diuretics 
as women with bulimia are prone to do.  Women with binge eating disorder must binge 
on average 2 days week for a period of 6 months (American Psychiatric Association, 
2000).   
 In summary, disordered eating symptoms can be found in a number of 
circumstances.  Some women had been found to restrict components of their dietary 
intake to maintain a slim or athletic appearance.  Other women may restrict their intake 
and strenuously exercise leading anywhere from brief perturbation to cessation of female 
hormones.  There are women whose dietary intake is increased or decreased due to their 
experiencing DSM IV TR (American Psychiatric Association, 2000) depressive or 
anxiety disorders.  Women can experience Anorexia Nervosa, Bulimia Nervosa and 





Metabolic and Hormonal Signals of Energy Balance 
Metabolic signals.  Hypothalamic neuronal pathways are responsible for energy 
homeostasis through regulation of appetite, energy expenditure and metabolism (Flier, 
2006).  Metabolic building blocks of metabolism include the metabolic fuels that regulate 
cellular and organism homeostasis: glucose, free fatty acids, and branch-chain amino 
acids (Coda, 2006; Flier, 2006). 
Hormonal signals.  Energy homeostasis is accomplished via hypothalamic neural 
circuits receiving and responding to peripheral signals that express the condition of 
energy fluxes and balance (Flier, 2006).  Many peripheral signals have been identified. 
Leptin, an adiposite hormone, is a messenger signifying energy availably (Ahima et al., 
1996).  Leptin effects body weight, eating behavior and satiety, and energy expenditure 
primarily through its effect on the hypothalamus (Friedman, 2002), and leptin affects 
reproduction through its effects again on the hypothalamus, anterior pituitary 
gonadotropes, ovarian follicular development and preparation of the endometrium for 
implantation (Moschos et al., 2002).  Low circulating leptin is a signal to the brain of 
nutritional shortage, and excess leptin can signify leptin resistance, particularly in obese 
individuals.  Other peripheral regulatory signals (Broberger, 2005) include gut-derived 
peptide hormones secreted with meals that support appetite (ghrelin) or satiety 
(Cholecystokinin CCK and peptide YY). 
Role of leptin.  For the purpose of this research, leptin will be discussed because 
of its role as a metabolic signal and as a critical hormone/cytokine in reproduction.  
Leptin has important effects that influence body mass, metabolism and reproductive 
function among other important physiological processes (Friedman, 2002; Moschos et al., 
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2002).  Leptin is a protein hormone, which is secreted primarily by adipocytes:  
Although, leptin is also expressed in the hypothalamus, pituitary, gastric epithelium, 
skeletal muscle, syncytiotrophoblast (which leads to placenta development), and 
mammary epithelium (Moschos et al. 2002).  Leptin receptors have been found in the 
hypothalamus, the pituitary gonadotrope cells, ovarian granulosa, theca and interstitial 
cells, and endometrium.  Moschos et al. (2002) view the multiple sites of leptin secretion 
and existence of leptin receptors at many levels of the HPG axis as support for nutritional 
and leptin regulation of the reproductive system.   
Leptin levels in healthy volunteers.  Studies of normal weight healthy study 
participants provide a foundation to understand physiological responses to low nutritional 
intake and explain results of leptin studies in women with eating disorders (Wolfe et al., 
2004).  Circulating leptin was measured in healthy subjects following a short-term fast.  
The decrease (~50%) in circulating hormone was unexpectedly large compared to the 
amount of weight loss (0.5%) (Boden et al., 1996).  Significantly decreased leptin levels 
were also found in 28 healthy subjects in response to a one week energy restriction 
(Dubuc, Phinney, Stern, & Havel, 1998) and in 15 well normal-weight study subjects 
after following a 4 week  low caloric diet (Wolfe et al., 2004).  At the end of the 4 week 
weight loss period, circulating leptin levels were significantly decreased (60.3%). 
Leptin in women with eating disorders.  Significantly lower serum leptin levels 
(p = 0.02 bulimia; p = 0.01 recovered bulimia) were found in 18 women with bulimia 
nervosa and 15 women with recovered bulimia nervosa compared to normal controls 
(Jimerson et al., 2000).  Grinspoon et al. (1996) examined serum leptin levels in 22 
women with anorexia nervosa and in 23 healthy volunteers and found reduced leptin 
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levels correlated with body fat but not dietary intake.  Levels of circulating leptin were 
also reduced in women with anorexia nervosa, as would be expected relative to their low 
fat mass (Monteleone, Fabrazzo, Tortorella,  Fuschino, & Maj, 2002).  Leptin levels 
(cerebral spinal fluid and serum levels) were found to return to normal prior to 
normalization of body mass in 11 women with anorexia nervosa (Mantzoros et al., 1997).  
The study outcome led Mantzoros et al. to question if the early return to normal leptin 
levels contributes to curtailed weight recovery.  
 Taken together, the above studies of leptin suggest that circulating leptin 
measures energy balance.  Given the decreases in leptin even with short-term fasting, 
serum leptin is sensitive measure of current energy balance. 
Leptin in women with amenorrhea.  Miller et al. (1998) investigated body mass 
via dual x-ray absorptiometry (DXA) and dietary intake on serum leptin in 21 normal 
weight women experiencing hypothalamic amenorrhea and in 30 healthy volunteers. 
Total nutritional intake, fat intake, and insulin levels were significantly lower in the 
women with hypothalamic amenorrhea. Significant hypoleptinemia was found in women 
experiencing hypothalamic amenorrhea compared with the healthy volunteers, possibly 
reflecting inadequate nutritional intake. 
Recombinant human leptin was administered to 8 women with hypothalamic 
amenorrhea associated with demanding physical exercise or low weight (Welt et al., 
2004).  Six women with hypothalamic amenorrhea served as controls. Reproductive, 
thyroid, growth hormones, and leptin were assessed in both groups.  Three of the eight 
women (p < 0.05) receiving recombinant leptin experienced an ovulatory menstrual 
cycle.  Another two leptin treated women developed a preovulatory follicle without 
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ovulation.  Leptin administration improved reproductive thyroid and growth hormone 
measures in the treatment group, providing additional support that leptin is necessary for 
fertility and normal neuroendocrine balance.  Finally, Ahima et al. (1996) found that 
giving leptin restored ovulatory function in a comparative model.  
Summary 
 Infertility is one of the most common health problems facing couples and an 
estimated 7.4% of women have problems conceiving (NSFG, 2002).  Infertility has 
multiple causes including ovulatory dysfunction, tubal and peritoneal pathology, male 
causes, endometriosis, and unexplained infertility.  Studies conducted at reproductive 
centers and biobehavioral studies link disordered eating symptoms and ovulatory and 
unexplained infertility.  However, few these studies had control or comparison groups 
allowing generalization to other women with infertility. 
 While psychological, biological, social and cultural factors may initiate eating 
disorders, the effect of too little or too much nutrition on energy balance likely triggers 
physiologic events ultimately affecting reproduction.  Chapter two describes a conceptual 
model synthesized from an understanding of normal hormonal functioning, Wade’s 
metabolic fuel hypothesis and the role of leptin as a metabolic and reproductive hormone 
to explicate the link between ED and infertility.  Further investigation of ED in women 
with ovulatory and unexplained infertility is warranted given their risk of poorer maternal 
and fetal outcomes.    
 Extending research to the study of disordered eating symptoms in infertility is 
worthy of clinical nursing research.  Investigating women with ovulatory and 
unexplained infertility and a comparison group of women receiving routine care from 
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their PCP for evidence of disordered eating symptoms using a larger sample and a 
comparative, descriptive design may provide definitive support that further nursing 
research is warranted.  Nursing research in the area of disordered eating symptoms and 
infertility is within the National Institute of Nursing Research’s initiatives for 







 A descriptive, comparative quantitative design was used to compare disordered 
eating symptoms in women with ovulatory and unexplained infertility and women 
receiving routine care from their primary care provider (PCP) at a large metropolitan 
academic general hospital medical center.  This chapter describes the recruitment,  
recruitment settings, data collection procedures and instruments, human subject 
protections, and the data analytical methods utilized to answer the research questions. 
Research Design 
A descriptive, comparative quantitative design was employed to test the stated 
hypotheses:  After controlling for selected variables (age, income, education, marital 
status, work status, race, and BMI), women experiencing ovulatory and unexplained 
infertility will report (1) significantly more disordered eating symptoms than women 
receiving routine healthcare from their PCP; (2a) significantly more current DSM IV TR 
(American Psychiatric Association, 2000) Axis I eating disorders than women receiving 
routine healthcare from their PCP; (2b) significantly more past DSM IV TR (American 
Psychiatric Association, 2000) Axis I eating disorders than women receiving routine 
healthcare from their PCP; and (3) significantly more symptoms of depression, anxiety, 
and dietary restraint than women receiving routine healthcare from their PCP. 
Sample 
 The sample size was originally set for 200 women: 100 women with ovulatory or 
unexplained infertility and 100 women in the comparison group receiving routine 
healthcare.  The proposed sample size was calculated using SamplePower, version 2.0 
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(SPSS, 2000).  The parameters used to determine the sample size were and alpha set at 
.05, power of .80 and a low moderate effect size.  Following a preliminary analysis, the 
final sample size was 85 (51 women with infertility and 34 women receiving routine 
health care), which yielded a power of .82 to 1.0.  In addition, the instruments for 
hypotheses 1 and 3 explained most of the variance in the analyses.  Recruitment of 
women was based on the study inclusion and exclusion criteria. 
Inclusion criteria.  Inclusion criteria for women with infertility were as follows:  
(a) age 18 to 44 years; (b) reported diagnosis of an ovulation disorder or unexplained 
infertility; (c) in stable medical condition and (d) able to speak, read and understand 
English.  The comparison group included a real world sample of women receiving routine 
health care from their PCP at a general hospital medical center.  Inclusion criteria for 
women in the comparison group are (a) age 18 to 44 years, (b) in stable medical 
condition, (c) not currently experiencing infertility and (d) able to speak, read and 
understand English. 
Exclusion criteria.  Women experiencing current unstable major medical 
illnesses will not be included in either group of participants. Women with tubal disease, 
endometriosis, or peritoneal effects will not be included unless they also experience co-
occurring ovulation or unexplained infertility.  Couples seeking infertility treatment due 
to male factors were included if the women also experienced ovulatory or unexplained 
infertility. 
Setting 
 Three healthcare sites were utilized to recruit study participants.  These sites 
included a Boston In Vitro Fertilization Center, Brigham and Women’s Center for 
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Infertility and Reproductive Surgery, and the Beth Israel Deaconess Medical Center 
Internal Medicine sites.  
Boston IVF is a highly specialized private fertility treatment center dedicated to 
in-vitro fertilization located in the metropolitan Boston area. Affiliated with the BIDMC, 
a major teaching center of Harvard Medical School, Boston IVF has clinics in Brookline, 
Waltham and Quincy and affiliated practices in three states and Bermuda.  The Waltham 
site was utilized for the recruitment of the group of women experiencing infertility. 
Recruitment of women with infertility was expanded in the spring of 2009 to 
include the recruitment of women with infertility from a general hospital infertility 
center, the Brigham and Women’s Hospital, Center for Infertility and Reproductive 
Surgery.  The Center for Infertility and Reproductive Surgery involves a committed team 
of academic physicians, embryologists, nurses, social workers, physician care assistants, 
and other personnel who are dedicated to helping couples build families through offering 
comprehensive reproductive services.    
Women receiving routine healthcare from their primary care provider (PCP) were 
recruited from the Beth Israel Deaconess Medical Center Healthcare Associates and the 
Women’s Center.  Healthcare Associates (HCA) is a hospital based primary care teaching 
practice comprised of faculty physicians, rotating medical house staff, nurse practitioners, 
triage nurses and clinical social workers.  HCA provides medical and mental health care 
to over 36,000 patients with 100,000 visits annually.  The Women’s Center provides 
expert primary care and mental health services that address an extensive scope of 
women’s health issues from preventative care to specialized treatment of disorders and 
conditions specific to women.  The team at the Women’s Center is comprised of 
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Figure 3  
 
Flow Diagram for Study Recruitment, Consent, and Meeting Goals for Data Collection. 
Boston  IVF 
& BWH Center for 
Infertility 
Reproductive 
Surgery:  Brochures   
invite women with 
ovulatory or 
unexplained 
infertility to call  
Women call 
PI in response 
to study 
brochure (53)  
Women call 
PI in response 
to study     
brochure (38) 
PI contacts  
and  explains 
study & verbal 
consent 





















Center & HCA: 
Brochures  invite 
women receiving 
routine care from 
their PCP  to call  
 Prior to initiation of the study, the study plan was presented to the clinical staff at 
BIDMC Healthcare Associates Practice Committee and the Women’s Center, Boston IVF 
Waltham Center, and the Brigham and Women’s Hospital Center for Infertility and 
Reproductive Surgery (Figure 3).  
 Brochures describing the study were left in the waiting room of each center.  The 
brochures directed women, interested in hearing more about the study, to call a 
confidential voice mail (or e-mail the PI) and leave a message about convenient days and 
times of their choosing to receive a return telephone call.  The investigator contacted the 
potential participants by telephone and provided a brief overview of the study.   The 
telephone call was placed at a time requested by the potential participant.  The procedures 
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regarding the number of telephone contacts (limit < 5) to potential participants were 
strictly followed.  
If the woman was interested in participating in the study, verbal informed consent 
was obtained by telephone (Appendix). Questions about the study were solicited by the 
PI to ensure that the woman fully understood the material presented.  Additionally, the PI 
was careful to discuss the steps taken to ensure confidentiality of the participant’s 
responses.  After the woman provided verbal consent, the study packet containing the 
self-report tools, a demographic information sheet, a letter containing the information 
presented in the verbal consent and a stamped investigator-addressed envelope was sent 
by mail to her home.  
A small stipend was sent via US mail to the participant. The woman received a 
stipend in the form of a gift card ($30.00).  Participants were asked to choose a card from 
CVS, Walgreen’s, Dunkin’ Donuts, or Starbucks Coffee. 
Data Collection Procedures 
After the participant provided verbal informed consent, a study packet with the 
study measures was mailed to her home.  A stamped, investigator-addressed envelope 
was included to facilitate return of the study responses to the investigator.  A letter in the 
packet provided the telephone number of the investigator and dissertation committee 
chair should the participant require clarification of any questions on the measures.  If the 
packet was not returned within two weeks of the mailing, the investigator contacted the 
participant by telephone to assure that any remaining questions or concerns were 




Data Collection Instruments 
Study participants were asked to score five self-report instruments and a brief 
demographic information sheet (Appendix).  Participants were asked to complete all of 
the self-report ratings within a one hour time period.  Table 1 lists the study measures to 











EDI-3-RF Measurement of  
eating disorder 
risk, BMI  
25 5 - 10 minutes Drive for  thinness, 
Bulimia, and Body 
Dissatisfaction Scales  
EDI-3-SC Determine DSM-
IV-TR  Axis I 
eating disorder 
diagnostic criteria 
9 categories <10 minutes Descriptive responses 
on specific eating 
behaviors, dieting, 




dietary restraint  
10 5 minutes Long-term dieting 
behavior 
BDI-II Measurement of 
depression  
20 5 - 10 minutes Depressive symptoms 
STAI form Y Measurement of 
anxiety 
40  <12 minutes Trait anxiety 
State anxiety 
 
Demographic information sheet.  A demographic questionnaire (Appendix C) 
included questions such as age, education, income, work status, race and ethnicity, 
highest level of education, and a place to check whether or not they had ovulatory 
infertility, unexplained infertility, or no infertility (comparison group).   
Eating Disorder Inventory-3-Referral Form.  The Eating Disorder Inventory-3-
Referral Form (EDI-3-RF; Garner, 2004) was used in the study to identify women at risk 
for developing an eating disorder.  The EDI-3-RF was developed to assist with the 
identification and referral of individuals vulnerable to developing eating disorders.  A 4-
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page booklet containing an Answer Sheet, a Scoring Sheet, and a Referral Sheet 
comprised the RF.  The Answer Sheet had two sections with 39 items.  Information on 
height and weight was collected on the back page of the booklet to allow for calculation 
of BMI.  The EDI-3-RF was recommended for screening use in new settings, such as 
infertility centers, and takes 5-10 minutes to complete (Garner, 2004). 
The EDI-3-RF utilizes the Eating Disorder Inventory-3 three subscales with 25 
questions that make up the Eating Disorder Risk Scales.  These subscales are the Drive 
for Thinness (DT), Bulimia (B), and the Body Dissatisfaction (BD) Scales and comprise 
the Eating Disorder Risk Composite.  The DT scale has seven items that evaluate extreme 
concern with restraining dietary intake and fear of gaining weight.  The B scale has 8 
items that evaluate the propensity to consider and engage in bursts of marked out of 
control eating.  The BD scale has 10 items that evaluate distress and dissatisfaction with 
the size and shape of body regions (buttocks, hips, stomach and thighs).     
Information sought by the EDI-3-RF included weight (highest, lowest, and 
desired), height and weight loss in the past 6 months.  Additional questions covered the 
frequency of binges, making one-self sick (vomiting), laxative use, or exercising for 60 
minutes or more to control weight or shape.  The EDI-3 Eating Disorder Risk Scales are 
written at the fourth grade reading level.  Information about the EDI-3 DT, B, and BD 
subscale reliability and sample was used to discuss the EDI-3-RF subscale reliability. 
The EDI-3 was developed on a large US clinical multi-site sample separated into 
four different diagnostic groups, a large international clinical sample, and a US and 
international nonclinical sample for comparison purposes (Cumella, 2006).  Exploratory 
factor analysis (EFA) examined the underlying relationships of the EDI-3 items in 
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diagnostic subgroups and in a non-patient sample.  The EFA solution for the EDI-3 led to 
more conceptually precise items and wider conceptual focus for the composites than the 
previous version (EDI-2; Garner, 2004). 
 Items on the EDI-3 were presented in a 6 point, forced-choice format that required 
respondents to indicate whether or not a specific item pertains by selecting one of the 
following choices: Always, Usually, Often, Sometimes, Rarely or Never (Garner, 2004). 
Each item was scored from 0 to 4 with the most severe replies in the pathologic direction.  
The pathologic direction of an item is given a 4, determined by the positive (Always) or 
negative (Never) direction of the item.  The adjoining response is given a 3, the 
subsequent response is given a 2, the next adjacent response a 1, and the two last 
responses are given a 0 since they are in contradistinction to the pathology.  Scale scores 
for a particular subscale are achieved by summing the items. 
 Reliability and validity for the EDI-3 using the 0 to 4 scoring system is available 
for a US and international sample of adults and adolescents (Garner, 2004).  Subscale 
reliabilities were in the high .80s to low .90s for the normative groups with comparable 
reliabilities for the four diagnostic groups (Anorexia Nervosa-Restrictive (AN-R), 
Anorexia Nervosa-Binge/Purge (AN-B/P), Bulimia (BN), and Eating Disorder Not 
Otherwise Specified (EDNOS)) except for the AN-R group, which expectedly 
demonstrated a lower score range.  Item-total correlations were uniformly high, as can be 
expected from the fairly high internal consistency reliability estimates (Garner, 2004). 
Established parameters identify individuals at risk for developing an eating 
disorder for referral: the individual's BMI only, BMI along with EDI-3 questions about 
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intense eating preoccupation, and on the responses given to behavioral questions 
pertaining to eating disorder pathology (Garner, 2004). 
Finally, the willingness of women with eating disorders to honestly respond to 
self-report measures is likely linked to the fidelity of efforts to maintain confidentiality 
(Garner, 2004).  Garner recommends care be taken to guarantee confidentiality to ensure 
that participants respond truthfully.  He further recommended that the self-report measure 
not be administered at the recruitment site and be mailed directly to the investigator.  For 
this reason, the consent process and rating scales were not administered at the recruitment 
sites.  Also, care was taken to ensure the participant understood that her responses would 
remain confidential. 
Eating Disorder Inventory -3- Symptom Checklist.  The EDI-3-Symptom 
Checklist (EDI-3-SC; Garner, 2004) was utilized to determine whether or not study 
participants met DSM IV TR (American Psychiatric Association, 2000) Axis I eating 
disorder criteria.  The EDI-3-SC (Garner, 2004) is a structured self-report inventory 
requesting current and historical details about the person's eating-related symptoms 
(binging, vomiting, frequency of exercise, compensatory behaviors) and menstrual 
history.  The EDI-3-SC systematically collects descriptive symptom data that assists in 
determining if the individual’s symptoms meet diagnostic criteria for any of the DSM-IV-
TR (American Psychiatric Association, 2000) eating disorders.  Items indicated with an 
asterisk identify information required in making an eating disorder diagnosis by DSM IV 
TR (American Psychiatric Association, 2000).  The EDI-SC is written at a sixth grade 
reading level and generally takes less than 10 minutes to complete. 
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The EDI-3-SC was used along with specific questions on the EDI-3-RF subscales 
to assess provisional lifetime, current and past eating disorders using the SCID (APA, 
2000) Module H along with the DSM IV TR manual EDNOS criteria.  Specifically, EDI-
3-SC symptoms were transcribed to Module H along with the EDNOS criteria from the 
DSM IV TR.  Select items from the EDI-3- RF subscales addressing attitudes in Module 
H (Appendix).  Past AN  and BN symptoms were often diagnosed as EDNOS due to 
limited information. 
Beck Depression Inventory II.  The Beck Depression Inventory II (BDI-II; 
Beck, Steer, & Brown, 1996) was utilized in the study to measure the level of depressive 
symptoms.  The BDI II has a strong empirical foundation, supported by 40 years of 
research.  The BDI was also utilized in Domar, Broome, Zuttermeister, Seibel, and 
Friedman (1992) investigation of depression in women with infertility.  The BDI-II is the 
most recent adaptation of the Beck, Ward, Mendelson, Mock and Erbaugh (1961) 
original self-report rating scale for depression.  The original items of the scale were 
established from verbal descriptions by patients and were not theory derived.  The BDI-II 
was modified from the widely used BDI I to be more in-line with the major depressive 
episode concept as characterized in the Diagnostic and Statistical Manual of Mental 
Disorders-Fourth Edition (DSM-IV) (American Psychiatric Association, 1994).  The 
inventory’s items were assessed through an iterated, principal-factor analysis and a 
promax (oblique) rotation which yielded a 2-factor solution representing a somatic-
affective dimension and a cognitive dimension. 
Similar to the early versions of the scale, the BDI-II contains 21 items; each item 
assesses a specific symptom or attitude (Beck et al., 1996).  The items are weighted on a 
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0 to 3 point scale, and the person is asked to endorse statements covering symptoms or 
attitudes experienced over the past two weeks, which are graded on level of severity.  The 
respondent was asked to circle the highest weighting that applies.  A total score was 
computed by adding weights corresponding to the each of the participant’s 21 items. 
Empirically informed cut off scores, based on responses from outpatients with a 
diagnosed episode of major depression, are provided. 
 The BDI II was normed on 500 psychiatric outpatients with mood disorders, 
anxiety disorders, adjustment disorders and other disorders as well as college students 
(Beck et al., 1996).  Internal consistency was evaluated using corrected item-total 
correlations (ranges: .39 to .70 for outpatients; .27 to .74 for students) and coefficient 
alpha (.92 for the 500 outpatients; .93 for 120 students). 
The BDI I was written at a sixth grade level and it is assumed that the BDI II is 
also at the same level (Beck et al., 1996).  The BDI-II generally can be completed within 
5 to 10 minutes. 
Herman and Polivy Revised Restraint Scale.  The Herman and Polivy Revised 
Restraint Scale (Herman & Polivy, 1980) was utilized in the study to measure dietary 
restraint.  Originally designed in 1973 to identify dieters who maintained a weight below 
set point (the level at which weight tends to stabilize), the Restraint Scale (Herman & 
Polivy, 1980) is now regarded as a measure of cognitive control of eating, disinhibition, 
and hunger (Herson & Bellack, 1986).  Soon after the introduction of the scale, Polivy 
and Herman (1985) identified that restrained eating contributes to disinhibited eating 
behavior.  Average dieting behavior was clarified to consist of periods of restraint 
counterbalanced by periods of disinhibited eating.  Therefore, the scale does not give 
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primacy to successful restrained eaters.  Instead, those individuals with a tendency toward 
disinhibited eating score the highest, and the scale selects dieters that weigh well above 
set point (Polivy, 1978).  The scale best identifies individuals with an enduring focus on 
dieting. 
 The Restraint Scale was developed using a sample of college students (166 male; 
348 female) (Herman & Polivy, 1986).  The scale can be considered unifactorial. 
Especially with females, the first unrotated factor explained 32% of the variance using 
principal components analysis.  The loadings on the first principal component were high 
in both genders (male .32 to .72; female .29 to .81) allowing for use as a unidimensional 
scale.  Later varimax rotation provided a 2-factor solution.  The first factor covered diet-
related cognitions, and the second factor reflected weight fluctuations.  However, neither 
factor alone seemed superior to the total scale (Herman & Polivy, 1986). 
The Restraint Scale is comprised of ten items that measure individual focus on 
weight and dieting (Herman & Polivy, 1986).  The multiple choice questions address 
weight fluctuations, extent of enduring dieting, and associated perspectives regarding 
weight and eating.  The multiple-choice answer format has four (0, 1, 2, 3) or five (0, 1, 
2, 3, 4) response options, with no reversed items.  Scores range from 0 to 35. 
Item total correlations spanned from .41 to .77 for female and .30 to .67 for male 
students (Herman & Polivy, 1986).  Test-retest reliability (1 week) was high (r = .95) 
with satisfactory internal consistency (alpha coefficient = .82) in a sample of 
undergraduates (Alison, Kalinsky, & Gorman, 1992).  Most studies have used the median 
split to contrast restrained and unrestrained subjects. 
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 The restraint scale has been widely used to identify individuals at risk for 
disinhibition of dieting behavior, such as those who disinhibited in response to 
preloading, who eat more during an emotional response, and who overeat in response to 
alcohol (Herman & Polivy, 1986).  The Restraint Scale is written at a fourth grade 
reading level, and can be completed in 5 minutes. 
Spielberger State-Trait Inventory.  The State-Trait Anxiety Inventory Form Y 
(STAI; Spielberger, 1989) will be utilized in the proposed study to measure anxiety.  The 
STAI Form Y (Spielberger, 1989) is a 40-item self-report instrument that measures both 
transitory anxiety (state [S] anxiety) and general long-standing anxiety (trait [T] anxiety) 
in adults.  Development of the instrument initiated in 1964.  Items from three widely used 
scales were rewritten with the psychological intent preserved to differentiate state and 
trait anxiety.  The STAI Form Y (Appendix F), utilized in this investigation, is the third 
iteration of the state and trait scales. 
Normative data for Form Y was collected from 5081 individuals (working adults, 
college students and military recruits) (Spielberger, 1989).  The factor structure for Form 
Y was assessed using the principle axis method of factor extraction, rotated by varimax to 
yield a four-factor solution; state-anxiety present items, state-anxiety absent items, trait-
anxiety present items and trait-anxiety absent items. 
Each item of the STAI Form Y is rated on a four-point Likert-type scale 
(Spielberger, 1989).  The State Anxiety (S-Anxiety) scale consists of twenty statements 
that assess how respondents feel “right now, at this moment” based on the intensity of 
anxiety where 1 = Not At All, 2 = Somewhat, 3 = Moderately So, and 4 = Very Much So. 
The S-Anxiety scale contains 20 items.  The S-Anxiety scale is comprised of ten anxiety-
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present items, which are scored from 1 to 4, and ten anxiety-absent items (1, 2, 5, 8, 10, 
11, 15, 16, 19, and 20), which also are scored from 1 to 4 and require reverse scoring 
prior to statistical analysis (Spielberger, 1989). 
The Trait Anxiety (T-Anxiety) scale asks participants to rate the frequency of 
anxious feeling where 1 = Almost Never, 2 = Sometimes, 3 = Often, and 4 = Almost 
Always.  The T- Anxiety scale is composed of eleven anxiety-present and nine anxiety-
absent (21, 23, 26, 27, 30, 33, 34, 36, and 39) items scored 1 to 4.  The anxiety-absent 
items of the T-Scale require reverse scoring prior to statistical analysis. 
The weighted scores for the twenty items on the T-Anxiety scale are summed and 
recorded on the allotted space on the test form (Spielberger, 1989).  Where one or two 
items are omitted on the instrument, the mean weighted score is computed, multiplied by 
20, and rounded to the next higher whole number.  Omitted responses in excess of two 
place the validity of the scale in question. 
Due to the fluctuating nature of anxiety states, measures of internal consistency 
(alpha coefficients) provide a more meaningful indicator of the S-Anxiety scales than 
test-retest correlations (Spielberger, 1989).  Alpha coefficients across groups and gender 
ranged from .89 to .93 indicating that Form Y has superior psychometric properties.  The 
alpha coefficient for females in the age range from 19 – 39 was .92. 
The STAI Form Y (Spielberger, 1989) will be utilized in this investigation.  Form 
Y- is written at the fourth to fifth grade reading level and takes five minutes to complete. 
Human Subjects Protection 
Approval of the study was sought through the Boston College (BC) Institutional 
Review Board (IRB) and the Beth Israel Deaconess Medical Center (BIDMC) Committee 
63 
 
on Clinical Investigations (CCI).  The principal investigator (PI) was a nonphysician 
member of the BIDMC physician group and worked for a BIDMC research group.  The 
BC IRB and the BIDMC CCI approved research at each of the sites designated in the 
proposed project for data collection: the Boston In-Vitro Fertilization (IVF) infertility 
clinic and the BIDMC Women’s Center and HCA practices.  The two IRBs also 
approved the use of BWH Center for Infertility and Reproductive Surgery as a 
recruitment site.  
Consent Process.  Women who call the self-referral telephone number received a 
return call from the PI on a day and at a time of their choosing.  No messages were left on 
the woman’s voicemail.  Women were first provided a brief overview of the study by the 
PI and asked if they would consider participation.  A verbal informed consent was then 
read to women interested in participating in the study (Appendix A).  Participants were 
asked to review the letter containing the informed consent in the packet, prior to filling 
out the self-report tools.  Over 90 women called and were later contacted and consented.    
When the woman provided verbal consent, a packet of instruments, the 
demographic questionnaire, and the verbal consent in letter form were be sent via mail. 
The return of the completed instruments by US mail to the PI implied consent.  No 
woman who self-referred refused participation at the time of the consent process.  
However, 5 women did not return their packets and one returned her packet well after 
data analysis was complete. 
Risk/Benefit Assessment.  The study had clinical intervention component; and 
therefore, the study was expected to be of no direct benefit to the study participants.  The 
study posed minimal risk of serious psychological response.  Filling out the self-report 
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instruments may have been tedious for some participants.  Study participants with active 
ED symptoms may possibly be stressed by the nature of the questions covering eating 
patterns.  However, a contact numbers for the principal investigator and the dissertation 
chair were provided to the study participant along with the study instruments.  While the 
plan was that participants expressing distress would be assessed by the PI (an advanced 
practice psychiatric nurse) and if necessary, a referral made, no participants called due to 
stress.  Two of the participants called because their packet was lost in the mail and 
another called requesting feedback on her instrument scores. 
 All participant responses and total inventory scores to the self-report measures 
were evaluated by the PI.  Participants who meet EDI-3-RF referral criteria or were rated 
with high scores on the BDI-II (or indication of suicidal thinking) were be re-contacted 
by telephone, as detailed in the verbal informed consent.  The participant was be assessed 
by the PI and appropriate referral recommended if necessary.   
Information obtained from the study could possibly contribute to an increased 
understanding of the role of disordered eating symptoms in ovulatory and unexplained 
infertility.  A finding of significantly greater disordered eating symptoms in the study 
participants with infertility may point to the need for further inquiry related assessment of 
early intervention with this population. 
Privacy and Confidentiality.  All research materials were stored in locked file 
cabinets which are located in a locked room.  The Screening Form from potential 
participants were given a 3 digit identification (ID) number.  Women who agreed to study 
participation were assigned a 4 digit study subject number. The subject ID number was 
used on all data collection measures, and the code chart was kept in locked file separate 
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from collected study data.   Also, screening forms of the study participants were kept in a 
separate locked file cabinet from the participant study data.  All study data were entered 
in password protected Statistical Package for the Social Sciences (SPSS) for Windows, 
version 16.0 files on a password protected computer located in a locked room. 
Data Analysis Plan 
After entering data into SPSS for Windows, version 16.0, all inputted data were 
checked prior to proceeding to the data analysis.  Multivariate analysis of covariance 
was computed for hypotheses one and three.  Chi square was used to test hypothesis 
two.  Chapter IV details preparation of the data to answer the research questions and the 
















The purpose of the study was to investigate disordered eating symptoms in women with 
ovulatory and unexplained infertility in comparison to a group of women receiving routine 
health care by their primary care providers.  Chapter 4 describes the study results including 
sample demographics and the primary analyses for hypothesis-testing.  Data were analyzed 
using SPSS for Windows, version 16.0. 
Description of the Sample 
 Table 2 reports frequencies and percents for the nominal level demographic variables. 
Nominal demographic variables with insufficient number were recoded and used in subsequent 
analyses (Table 3).  Table 4 reports descriptive statistics for the continuous variables broken out 
by group.  The mean age was 34.4 years (SD 4.8) for the infertility group and 31.2 years (SD 
6.5) for the women receiving routine health care.  Over 96% (n=49) of the women with 
infertility were married compared to 18% (n=6) women receiving routine health care.  Seventy-
eight percent (n=40) of the women with infertility were White as were 62% (n=21) of the 
women receiving routine health care.  Seventy-eight percent (n=40) of the women with 
infertility were working full or part-time compared with 62% (n=21) of the women receiving 
routine health care.  Ninety-eight percent (n=50) of the women with infertility had post 







Demographic Data by Group for the Original Data with Missing Values 




group n = 34 (%) 
Marital status Missing 0   (0.0) 1   (2.9) 
 Single/never married 2   (3.9) 21 (61.8) 
 Married 49 (96.1) 6 (17.6) 
 Separated 0   (0.0) 2   (5.9) 
 Divorced 0   (0.0) 4  (11.8) 
     
Race Missing 0   (0.0) 2   (5.9) 
 Asian East Southeast 5   (9.8) 1   (2.9) 
 Asian Western 2   (3.9) 1   (2.9) 
 Black or African American 1   (2.0) 7 (20.6) 
 White 40 (78.4) 21 (61.8) 
 Multi-racial 3   (5.9) 2   (5.9) 
     
Work status Missing 0    (0.0) 1    (2.9) 
 Full-time 36  (70.6) 15  (44.1) 
 Part-time 4    (7.8) 5  (14.7) 
 Not working outside home 11  (21.6) 13  (38.2) 
     
Educational level Missing 0    (0.0) 1   (2.9) 
 Some high school 0    (0.0) 1   (2.9) 
 High school grad 1    (2.0) 3   (8.8) 
 Some college 0    (0.0) 7 (20.6) 
 Associate degree 4    (7.8) 1   (2.9) 
 Bachelor’s degree 14  (27.5) 14 (41.2) 
 Master’s degree 23  (45.1) 6 (17.6) 
 Professional degree 6  (11.8) 1   (2.9) 
 PhD 3    (5.9) 0   (0.0) 
     
Income Missing 3    (5.9) 1   (2.9) 
 Under $20,000 8  (15.7) 12 (35.3) 
 $20,000 – $30,000 3    (5.9) 5 (14.7) 
 $30,000 – $40,000  2    (3.9) 4 (11.8) 
 $40,000 – $50,000 5    (9.8) 6 (17.6) 
 $50,000 – $75,000 13  (25.5) 5 (14.7) 
 $75,000 – $100,000 9  (17.6) 0   (0.0) 
 $100,000-$150,000 5    (9.8) 1   (2.9) 
 $150,000 and above 3    (5.9) 0   (0.0) 










Recoded Demographic Variables 
Variable  Infertility 
group (n = 51) 
n (%) 
Comparison 
group (n = 34) 
n = (%) 
Recoded Marital Status Married 49 (96.1) 6 (17.6) 
 Single, separated, Divorced 2   (3.9) 28 (82.4) 
     
Recoded Race White 40 (78.4) 21 (61.8) 
 All other races 11 (21.6) 13 (38.2) 
     
Recoded Work Full or part-time 40 (78.4) 21 (61.8) 
 Not working outside home 11 (21.6) 13 (38.2) 
 
Preparation of the Data for Hypothesis-Testing  
 After entering the study data into SPSS for Windows, Version 16.0, descriptive statistics 
were computed on all study variables and examined for the presence of random and / or 
systematic missing data, significant skewness, and outliers.  No systematic missing data were 
found.  Minimal random missing data were noted in study variables and were handled by mean 
substitution.  
The continuous variables were next examined for the presence of marked skewness. 
Fisher’s measure of skewness (skewness coefficient ÷ standard error of skewness) was 
employed to check for marked skewness. As Table 4 reports, three variables were significantly 
and positively skewed with cut off values greater than ±1.96 standard deviation units, namely: 
the Desire for Thinness, Bulimia, and BDI scales.  Applying the guidelines set forth by 
Tabachnick and Fidell (2007), logarithmic transformations undertaken to correct the problem 




Table 4  
 
Descriptive Statistics for Continuous Variables 
 
  Age Desire for 
Thinness 







Infertility n = 51         
 Mean 34.4 1.00 0.42 1.60 13.69 40.14 40.42  0.99 
 Median 34.0 0.57 0.25 1.40 14.00 40.00 39.00  0.57 
 SD   4.8 1.01 0.59 0.99  4.93 12.63 10.06  1.01 
 Minimum 24.0 0.00 0.00 0.00  4.00 22.00 23.00   0.00 
 Maximum 43.0 4.00 3.12 3.70 26.00 77.00 63.00 36.00 
 Skewness  1.30 2.45 0.36  -0.08   0.47  0.25   1.30 
 SE Skew  0.33 0.33 0.33   0.33   0.33  0.33   0.33 
Comparison n = 34         
 Mean 31.2 1.56 0.82 2.00 17.47 42.51 47.67 1.56 
 Median 31.0 1.29 0.63 1.95 16.00 41.82 46.42 1.28 
 SD   6.5 1.14 0.80 0.99  6.97 11.11 10.77 1.14 
 Minimum 20.0 0.00 0.00 0.00  6.00 21.00  31.00 0.00 
 Maximum 44.0 3.71 3.62 3.60     32.00 63.00  69.00     40.00 
 Skewness  0.29 1.53          -0.16  0.41  0.13   0.26 0.29 






Fisher’s Coefficient of Skewness Prior to and After Logarithmic Transformation 
 
Variable Desire for 
Thinness 
Log Transformed 
Desire for Thinness 
Bulimia Log Transformed 
Bulimia 
BDI Log Transformed 
BDI 
Mean  1.22  .17  .58  .33 13.24 1.73 
Median   .75  .17  .25  .36        11.0 1.71 
SD 1.10  .03  .71  .05    9.75  .08 
Skewness   .82 -.45 1.93 -.50    .87  .52 
SE**    .26  .26  .26  .26   .26  .26 
Fisher’s***   3.12*             -1.74  7.39*              -1.92   3.32*              1.95 
* Marked skewness 
**SE = standard error 









Internal consistency reliability of study instruments.  Cronbach’s alphas, internal 
consistency reliability coefficients, were next computed for the EDI – 3 – RF subscales (Desire 
for Thinness, Bulimia, and Body Dissatisfaction), The Herman and Polivy Restraint Scale, the 
STAI scales (State Anxiety and Trait Anxiety) and the BDI-II scale total scores. The Cronbach 
alpha coefficients ranged from .82 to .92 as depicted in Table 6.  All instruments had reliabilities 
above 0.80 indicating sufficient reliability to proceed with the formation of subscale and total 




Internal Consistency of Instruments 
 
Instrument Number of Items  Cronbach’s Alpha based  
on Standardized items 
Desire for Thinness Scale 7 .89 
Bulimia Scale 8 .86 
Body Dissatisfaction Scale 10 .88 
Restraint Scale 10 .82 
State Anxiety Scale 20 .92 
Trait Anxiety Scale 20 .92 











Hypothesis 1:  After controlling for participants’ age, income, education, marital status, work 
status, race, and current BMI, women experiencing ovulatory and unexplained infertility will 
report significantly more disordered eating symptoms than women receiving routine healthcare 
from their PCP. 
Hypothesis 1 was tested using a multivariate analysis of covariance (MANCOVA).  The 
three dependent variables were log transformed Desire for Thinness, log transformed Bulimia, 
and Body Dissatisfaction subscales.  The independent grouping variable was the infertility 
(ovulatory and unexplained) group (n = 51) and the comparison group (n = 34) of woman 
receiving routine health care.  The covariates were age, education, income, recoded marital 
status, recoded work, recoded race and current Body Mass Index (BMI).  Table 7 reports the 
omnibus F for the three dependent variables was significant (log transformed Desire for 
Thinness F = 2.91, df 15, p =.001; log transformed Bulimia F = 2.41, df 15, p =.007; Body 
Dissatisfaction F = 4.19, df 15, p = .000) using a Bonferroni correction of 0.0167.  
Table 8 presents the descriptive statistics by group for the dependent variable prior to and 
after adjustment for covariance influence. Table 9 reports the results for Box’s test for Equality 
of Covariance Matrices. The nonsignificant p of .72 indicates the assumption of equality of 
covariance matrices was met.  Levine’s Test of Equality of Error variances, shown in Table 10, 
was also nonsignificant supporting the assumption of homogeneity of variance of the dependent 
variables.   
Pillai’s Trace testing whether the groups significantly differed on the combined 
dependent variable mean scores was F =.278; df 3, 67; p =.84 indicating that the two groups 





Summary of Between Subjects Effects   
 




























































































































































Incomepart  Log Transformed 



















































































Summary of Between Subjects Effects (continued) 
 


















































































BMIcurr Log Transformed 






























































































































































Summary of Between Subjects Effects (continued)   
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Log Transformed 















    




































Box’s Test for Equality of Covariance Matrices 
 















Levine’s Test of Equality of Error Variances for Dependent Variables: EDI – 3 – RF subscales  
 
Scale F df1 df2 p 
Log Transformed Desire 




































A single factor MANCOVA was used to test the hypothesis.  Table 7 displays the results 
for each between subject effects on the individual dependent variable. Of the covariates, only 
current BMI was significant (log transformed Desire for Thinness F = 7.06; df 1; p = .010; log 
transformed Bulimia F = 9.51; df 1; p = .003; Body Dissatisfaction F = 39.21; df 1; p = .000) 
for all the dependent variables.  Of the two way group interactions, only education by group 
significantly (F = 6.34; df 1; p = 0.01) interacted with the Desire for Thinness subscale score 
and current BMI by group significantly (F = 9.11; df 1; p = .004) interacted with the Body 
Dissatisfaction subscale score.   
After removal of the covariate and interaction influences, there were significant 
differences between the groups on all 3 dependent measures.  The power for the corrected 
model ranged from .97 to 1.00.  Thus, after removal of the covariate and interaction influences 
the infertility group had significantly higher Desire for Thinness and Bulimia subscale scores 
and significantly lower Body dissatisfaction subscale scores than the comparison group.        











Hypothesis 2a: Women experiencing ovulatory and unexplained infertility will report 
significantly more current DSM IV TR (American Psychiatric Association, 2000) Axis I eating 
disorders than women receiving routine care from their PCP.   
Chi Square was utilized to test Hypothesis 2a.  As Table 11 reports, women with 
infertility did not have significantly more Axis I current eating disorders than the comparison 
group of women receiving routine health care. 
Hypothesis 2b: Women experiencing ovulatory and unexplained infertility will report 
significantly more past DSM IV TR (American Psychiatric Association, 2000) Axis I eating 
disorders than women receiving routine care from their PCP.   
Chi Square was also used to test Hypothesis 2b.  As Table 11 reports, women with 
infertility did not have significantly more Axis I past eating disorders than the comparison group 
of women receiving routine health care. 
Table 12 reports the rate and percent of Lifetime current or past ED diagnosis for the 
women with infertility and the women receiving routine health care from their PCP for later 
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 Total 51 60.0% 34 40.0% 85 
 























 Total 51 60.0% 34 40.0% 85 
 
  Current Diagnosis:  Pearson χ²(1, N = 85) = .242, p = .62 





Lifetime Current or Past ED Diagnosis:  Infertility and Comparison 
Groups 
 Infertility 
 group (51) 
Comparison 
group (34) 
 n (%) n (%) 
No diagnosis ever 
 
34 (66.7) 17 (50.0) 
Current ED diagnosis 
 
7 (13.7) 6 (17.7) 
Past ED diagnosis 
 
10 (19.6) 11 (32.3) 




Hypothesis 3:  After controlling for selected variables (age, income, education, marital status, 
work status, race, and current BMI), women experiencing ovulatory and unexplained infertility 
will report significantly more symptoms of depression, anxiety, and dietary restraint than women 
receiving routine healthcare by their PCP. 
Hypothesis 3 was also tested using (MANCOVA). The four dependent variables were the 
Restraint, State Anxiety, Trait Anxiety and the recoded BDI-II scale scores.  The independent 
group variable, the fixed factor, included infertility (ovulatory and unexplained) group (n = 51) 
and the comparison group (n = 34) of woman receiving routine health care. The covariates 
included age, education, income, recoded marital status, recoded work, recoded race and 
current BMI.  Table 13 reports the omnibus F for the Restraint scale score was significant (F = 
3.63, df 1; p = .000) using a Bonferroni correction of 0.0125).  
Table 14 presents the descriptive statistics by group for the dependent variable prior to 
and after adjustment for covariance influence. Table 15 reports the results for Box’s test for 
Equality of Covariance Matrices. The nonsignificant p of .57 indicates the assumption of 
equality of covariance matrices was met.  Levine’s Test of Equality of Error variances, shown 
in Table 16, was also nonsignificant supporting the assumption of homogeneity of variance of 
the dependent variables.  
Pillai’s Trace was used to test whether the groups significantly differed on the combined 
dependent variable mean scores.  Pillai’s trace was F = .51;  df 4, 66; p = .73 indicating that the 








Summary of Between Subjects Effects 

































































































































































































































































Summary of Between Subjects Effects (continued) 







Restraint score  
 




























































































































































































































































Summary of Between Subjects Effects (continued) 































































































































































































































































Summary of Between Subjects Effects (continued) 





























































Descriptive Statistics by Group for the Dependent Variables Prior to and After 
Covariate Adjustment 
Dependent Variables Group Unadjusted  Adjusted 
Mean (SD) Mean  (SE) 
Restraint scale Infertility 13.7  (4.93) 12.6  (1.40) 






State Anxiety scale Infertility 40.1 (12.63) 42.3  (3.50) 
 Comparison 42.5 (11.11) 44.7  (3.80) 
 Total 
 
41.1 (12.04)   
Trait Anxiety scale Infertility 40.4 (10.06) 40.9  (3.01) 
 Comparison 47.7 (10.77) 48.1  (3.26) 
 Total 
 
43.3 (10.89)   
Log BDI-II scale Infertility 1.7   (0.08) 1.7  (0.02) 
 Comparison 1.7   (0.07) 1.7  (0.02) 
 Total 
 
1.7   (0.08)   











































































A single factor MANCOVA was used to test the hypothesis.  Table 13 displays the 
results for each between subject effects on the individual dependent variables.  When 
examining for the influence for each main effect on the individual dependent variable of the 7 
covariates, only current BMI was significant for all the dependent variables.  Of the two way 
group interactions, only current BMI by group significantly (F = 13.79; df 15; p = .000) 
interacted with the Restraint scale score.   
After removal of the covariate and interaction influences, there was a significant 
difference between the groups on the Restraint scale score.  The power for the corrected model 
was .999.  Thus, after removal of the covariate and interaction influences the infertility group 
86 
 
had significantly lower Restraint scale scores but did not significantly differ on the State 
Anxiety, Trait Anxiety, BDI-II scale scores than the comparison group.  
Summary 
Hypothesis 1 was tested using MANCOVA.  The infertility and comparison groups were 
compared in terms of mean scores for the Desire for Thinness, Bulimia and Body Dissatisfaction 
Subscales, adjusted for the effect of 7 covariates by simultaneously testing each factor effect and 
interaction effect on the dependent variable.  The F was significant using a Bonferroni 
adjustment of 0.0167 for the three subscales.  The infertility group had significantly higher 
Desire for Thinness and Bulimia scale scores than the comparison group.  The mean Body 
Dissatisfaction scale scores for the infertility group were significantly lower than the comparison 
group scale scores.  Thus, hypothesis 1 was partially supported. 
Hypotheses 2a and 2b were tested using the Chi Square statistic.  The Chi Square results 
did not find that women with infertility has significantly more current or past Axis I eating 
disorders than the comparison group.  Thus, hypotheses 2a and 2b were not upheld. 
Hypothesis 3 was tested using MANCOVA.  Mean Restraint, State Anxiety, Trait 
Anxiety and BDI-II scale scores, adjusted for the effect of 7 covariates by simultaneously 
testing each factor effect and interaction effect on the dependent variables, were compared for 
the infertility and comparison group.  The F was significant, using a Bonferroni adjustment of 
0.0125, for the Restraint scale only.  Thus, hypothesis 3, as it was proposed, was not upheld. 
Chapter 5 discusses these results in detail.  Discussion and interpretation of these findings 







This study was designed to compare disordered eating symptoms in women with 
ovulatory and unexplained infertility and women receiving routine health care from their PCP at 
a general hospital medical center.  The parameters used in this descriptive, comparative 
quantitative study were self-report of eating and psychological symptoms on the EDI - 3 - Desire 
for Thinness, Bulimia, and Body Dissatisfaction subscales, The Herman and Polivy Restraint 
Scale, The Speilberger State and Trait Anxiety Scales, and the Beck Depression – II Inventory.  
Additional self-report information of specific ED symptoms and compensatory behaviors was 
obtained from the EDI – 3 – Symptom Checklist.  Group differences were significant for four 
measures of eating disorder symptoms with women with infertility scoring significantly higher 
on desire for thinness and bulimia symptoms and scoring significantly lower on body 
dissatisfaction and dietary restraint.  This chapter includes an overview of major study outcomes 
and a discussion of the results.  In addition, limitations of the study as well as recommendations 
for further study are presented. 
Group Characteristics 
 Study groups evidenced differences on several descriptive characteristics.  The infertility 
group was slightly older, predominately married, and had higher income and education levels; 
although, two/thirds of the comparison group also had post secondary degrees.  BMI was 
significantly lower in the infertility group t(42.4) = 2.5, p = .019.  The groups were similar on 





Interpretation of the Findings 
Hypothesis 1:  After controlling for participants’ age, income, education, marital status, work 
status, race, and current BMI, women experiencing ovulatory and unexplained infertility will 
report significantly more disordered eating symptoms than women receiving routine health care 
from their PCP. 
 As, hypothesized, the women with infertility reported significantly more eating disorder 
symptoms on the Desire for Thinness and Bulimia subscales than women receiving routine 
health care by their PCP.  Thus, eating disorder symptoms putting women at risk for Anorexia 
Nervosa (Desire for Thinness subscale) and Bulimia (Bulimia subscale) were significantly more 
evident in the group of women with infertility.  Conversely, the women with infertility reported 
significantly less eating disorder symptoms as measured by the Body Dissatisfaction subscale 
scores.   
The Body Dissatisfaction subscale measures disapproval with body weight and the shape 
of body areas (hips, stomachs, thighs and buttocks).  While these concerns prevail in Western 
culture, Garner (2004) views the construct of body dissatisfaction as a risk factor, influential in 
prompting and prolonging extreme weight management behaviors that could foster EDs in 
predisposed women.  Specifically, body dissatisfaction is influenced by weight and weight 
history.  Garner reports that individuals with higher BMIs have higher BD scale scores.  Looking 
at the mean BMI scores for the two groups (infertility M=23.81 [SD 4.1]; comparison M=27.74 
[SD 8.8]), the BD subscale scores are consistent with the lower BMI of the infertility group.  On 
the other hand, the women receiving routine healthcare had higher BD subscale scores consistent 
with their higher BMIs and tendency toward overeating.  
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Hypothesis 2a and 2b: Women experiencing ovulatory and unexplained infertility will report 
significantly more current and past DSM IV TR (American Psychiatric Association, 2000) Axis I 
eating disorders than women receiving routine care from their PCP.   
 Theses hypotheses were not upheld.  Women with infertility did not have more current or 
past Axis I eating disorders than the comparison group.  Use of the SCID Module H and the 
DSM IV EDNOS criteria without an interview to probe for further symptoms may have 
influenced the nonsignificant result.  Some women with infertility reported past EDNOS AN 
symptoms that were not as well covered by the EDI-3-SC instrument.  Specifically, the 
instrument focuses more on bulimia symptoms and less on historical AN disturbed attitudes, 
such as of perceived body weight on self-evaluation and denial of the gravity of low weight.  
Furthermore, lifetime diagnosis may be a better clinical diagnostic perspective to assess women 
with infertility.  Lifetime diagnosis addresses whether or not the participant ever met a threshold 
ED diagnosis.   
Recent prevalence studies provide a basis to better interpret the diagnostic results of the 
study.  These studies are the Hudson, Hiripi, Pope & Kessler (2007) report of national estimated 
lifetime prevalence data of ED and the Freizinger, Franko, Dacey, Okun and Domar (2010) 
report of lifetime diagnosis in women with infertility.  Hudson et al. examined the National 
Comorbidity Survey Replication for estimated lifetime prevalence of ED.  Using the results of 
the national, in person, WHO Composite International Diagnostic Interview, the researchers 
determined the national lifetime prevalence of AN was 0.9%, BN was 1.5%, and the provisional 
diagnosis BED had a lifetime prevalence of 3.5%.  Freizinger et al. reported on research 
conducted on 82 women with all infertility diagnoses recruited from an infertility center.  After 
providing verbal consent, women were administered the DSM IV Axis I Disorders (SCID I) 
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Module H along with the DSM IV manual EDNOS criteria by telephone.  Freizinger et al. found 
that 21% (17) of the women with infertility met ED criteria for either a past or current disorder, 
which was five-times the US estimated prevalence rate of 1-4%.   
Over 33% of the infertility group in the present study had a lifetime ED diagnosis based 
on symptoms transcribed to the SCID Module H along with the DSM IV TR manual EDNOS 
criteria.  Almost 6% (3) women with infertility met full criteria for a current (2; 3.9%) or past (1; 
2%) AN or BN.  However, over 27% of the women had a current (5; 9.8%) or past (9; 17.6%) 
EDNOS diagnosis.  Women with ovulatory infertility had current diagnoses within the 
constricting continuum (AN, BN- restricting and EDNOS [AN without amenorrhea]).  Past 
diagnoses were characterized primarily by restriction (4) with only two women having a 
diagnosis involving binging.  Women with unexplained infertility were more likely to report 
current diagnoses involving binging (3); although, these women reported past diagnoses 
representing both continuums (restricting [3] and binging eating [3]).  These results are in line 
but higher than the Freizinger et al. (2010) findings.        
Sample characteristics and the use of a different ED instrument may explain the higher 
percentage of women with lifetime ED diagnoses in the present study compared with the 
Freizinger et al. (2010) study.  The present study recruited of only women with ovulatory and 
unexplained infertility, diagnoses previously reported in early ED studies.  Additionally, the 
EDI-3-SC probes for specific bulimia symptoms and compensatory behaviors.  Finally, the study 
results are also similar to the research findings of Stewart et al. 1990.   
Hypothesis 3:  After controlling for participants’ age, income, education, marital status, work 
status, race, and current BMI, women experiencing ovulatory and unexplained infertility will 
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report significantly more symptoms of depression, anxiety, and dietary restraint than women 
receiving routine care from their PCP. 
 Although the hypothesis was not upheld, the study found that women with infertility had 
significantly lower Restraint scale scores than the comparison group.  Dietary intake in women 
with infertility was within the normal range.  Therefore, the women receiving routine health care 
had significantly higher restraint scale score.  The dietary intake of women receiving routine 
health care was characterized by restriction, possibly contributing to dietary disinhibition.  In 
contrast to the infertility group, six of the women receiving routine health care had current ED 
diagnoses.  Three women had BN; three women had EDNOS BED.  Three women in the 
comparison group had full criteria past diagnoses of AN (2) and BN (1); the rest of the subjects 
(8) had EDNOS diagnoses.  Therefore, their diagnoses more commonly fell under the bulimia 
and BED diagnoses.   
The higher rate of ED in the sample of women receiving routine health care from their 
PCP is also of great concern. The ED diagnostic trend toward the overeating continuum in the 
comparison group is similar to the Johnson, Spitzer, and Williams (2001) study of ED in women 
receiving primary care and obstetric gynecology care.  The researchers found a 6.2% prevalence 
rate of BN and BED and noted subjects in their sample experienced higher disability, lower 
functioning and medical co-morbidity.  Worth mentioning, 50% the comparison group in this 
study had a current or past ED, which was 8 times the percent Johnson, Spitzer, and Williams 
found.  The discrepancy could be explained by their use of a different self-rating instrument, the 
Spitzer et al. (1999) Patient Health Questionnaire.   
Thirty eight percent of the comparison group was comprised of minority women versus 
22% in the group of women with infertility.  Although previous research reports that minority 
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women have a similar prevalence of ED to Caucasian women (Franko, Becker, Thomas, and 
Herzog, 2007), 62% of the sample of minority women (n = 13) receiving routine health care in 
the present study had a lifetime ED diagnosis.  The group of women with infertility had less 
minority women (n = 11); still, the minority women with infertility also had an unexpectedly 
high rate (55%) of ED diagnoses.  However, 43% of the women receiving routine healthcare that 
self-reported as White also had ED diagnoses indicating the comparison group had higher 
lifetime ED diagnoses overall.  One explanation for the higher rates could be the age (M 31.2; 
SD 6.5) of the women participants which is considerably older than the women in other ED 
studies.  Finally, the higher percent of ED could be related to the specific comparison group 
recruitment setting that integrated mental health and psychiatry services into the internal 
medicine practices.    
 The women with infertility in the present study did not report significantly more 
symptoms of depression than the comparison group, a finding dissimilar to the Domar et al. 
(1992) study.  Domar et al. found higher rates of depression in women with 2 to 3 years of 
infertility.  In contrast, the women in the present study generally reported having infertility for 
less than two years, a time period generally characterized by greater hope of becoming pregnant.  
Also, women with a clear cut infertility etiology in the Domar et al. study had higher depression 
scores than women with unexplained infertility.  Sixty-three percent of the infertility group in the 
present study had unexplained infertility. 
 Similar to the findings of depression, the women in the infertility group did not report 
significantly more symptoms of anxiety than the comparison group of women receiving routine 
health care.  In fact, the comparison group of women had slightly higher Spielberger state 
anxiety and trait anxiety scores than the women with infertility.  However, the women with 
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infertility had elevated state and trait anxiety scores when compared with means of the normative 
sample of female working adults ages 19 to 39 (state anxiety: infertility [42.3, SE 3.5], female 
working adults [36.17, SD 10.96]; trait anxiety: infertility [40.9, SE 3.01], female working adults 
[36.15, SD 9.53].   
Studies of anxiety during early infertility treatment had equivocal results (Verhaak, 
Smeenk, Evers, Kremer, Kraaimaat & Braat, 2007).  The studies reporting elevated anxiety 
found that women with infertility had anxiety prior to initiation of IVF treatment (Beaurepaire, 
Jones, Theiring, Saunders, & Tennant, 1994; Salvatore, et al., 2001; Slade, Emery, & Lieberman, 
1997).   In the present study treatment for most of the women with infertility spanned from 
evaluation up to two years of treatment.  Additionally, women with ED have higher rates of 
comorbid anxiety (Gadalla & Piran, 2008; Pallister & Waller, 2008); and thus, the high 
prevalence of ED diagnoses in the women with infertility and in the women receiving routine 
health care may also explain the high anxiety scores.                 
Study Implications 
 The study results provide further support that women with ovulatory and unexplained 
infertility are at risk for having an occult ED.  Finding that women with ovulatory infertility had 
significantly more ED symptoms on the Desire for Thinness and Bulimia subscales and that they 
had provisional lifetime ED diagnoses many times in excess of the national ED prevalence rate 
provides support for the conceptual model for the study.  The Conceptual Model proposed that 
individual issues arising out of multiple explanations of behavior predispose women to eating 
disordered symptoms.  The related change in nutritional status leads to metabolic changes 
affecting reproductive function, specifically ovulatory dysfunction or unexplained infertility.  
Because the study was at the descriptive, quantitative level, the results cannot be interpreted in 
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terms of specific physiologic / metabolic processes influencing reproduction.  However, the 
results provide scientific justification to study the physiologic link and markers to better identify 
women with ED.      
 The results of this study provide additional support that women with ovulatory and 
unexplained infertility should be carefully assessed for current and past eating disorders.  
Assisted reproductive technologies (ART) can lead to pregnancy, but the procedures alone do not 
confer good pregnancy outcomes.  Women with a low BMI before and during pregnancy are at 
greater risk of delivering low birth weight (LBW) babies with greater risk of morbidity and 
mortality (Institute of Medicine, 1990).  Women who are overweight or obese before and during 
pregnancy are at greater risk of having gestational diabetes, hypertension and pre-eclampsia 
(Goldberg, 2002). Moreover, as BMI increases, the risk of these complications also increases 
(Linne, 2004).  Also, women with eating disorders who become pregnant have a higher 
incidence of cesarean section (CS), postpartum depression (PPD) and small for gestational age 
babies (Franko, Blais, Becker, Delinsky, Greenwood, Flores, et al., 2001; Moos, Dunlop, Jack, 
Nelson, Coonrod, Long et al., 2008).  Finally, women with eating disorders are at risk for 
recurrence of their eating symptoms due to body shape changes associated with postpartum fat 
deposits. 
 The Center of Disease Control and Prevention’s (CDC) Select Panel on Reproductive 
Health has set forth specific recommendations for health and wellness care of women of 
reproductive age (Moos et al, 2008).  They emphasize the value of integrating reproductive 
planning into the individual health promotion needs of every woman of childbearing age, 
regardless of pregnancy intention.   The Panel sites the Institute of Medicine’s recommendation 
of a prepregnancy low BMI cut point of < 19.8 km/m2 and the importance of assessing for eating 
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disorder symptoms and body shape distortions.  The Panel also recommends counseling women 
with BMIs ≥ 26 kg/m2 regarding associated health risks, including infertility. 
 Taking into consideration the results of the current and past studies on eating disorders 
and infertility, it is critical to integrate assessment for eating disorders into infertility evaluation.  
Assessment of women with infertility who have had eating disorders is crucial, as these women 
remain at risk for poor pregnancy outcomes.  The current study highlights that normal weight 
women with infertility can have ED, thus routine assessment of all women with infertility for ED 
is vital to better ART and pregnancy outcomes.  For that reason Andersen and Ryan (2009, p 
1353) caution reproductive endocrinologists to develop a “lower index of suspicion” of ED to 
ensure that ART treatments do not unintentionally contribute to maternal and fetal risk.  The use 
of a self-report tool such as the EDI-3-RF or the EAT would provide a means for discussion of 
eating issues in the infertility setting.  Most important, woman with ED require on-going 
psychiatric treatment during infertility treatment and pregnancy due to their at risk status. 
 The higher rate of ED in the sample of women receiving routine health care from their 
PCP is also of great concern. The ED diagnostic trend toward the overeating continuum in the 
comparison group is similar to the Johnson, Spitzer, and Williams (2001) study of ED in women 
receiving primary care and obstetric gynecology care.  The researchers found a 6.2% prevalence 
rate of BN and BED and noted subjects in their sample experienced higher disability, lower 
functioning and medical co-morbidity.  Worth mentioning, 50% the comparison group in this 
study had a current or past ED, which was 8 times the percent Johnson, Spitzer, and Williams 
found.  The discrepancy could be explained by their use of a different self-rating instrument, the 
Spitzer et al. (1999) Patient Health Questionnaire.   
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Thirty eight percent of the comparison group was comprised of minority women versus 
22% in the group of women with infertility.  Although previous research reports that minority 
women have a similar prevalence of ED to Caucasian women (Franko, Becker, Thomas, and 
Herzog, 2007), 62% of the sample of minority women (n = 13) receiving routine health care in 
the present study had a lifetime ED diagnosis.  The group of women with infertility had less 
minority women (n = 11); still, the minority women with infertility also had an unexpectedly 
high rate (55%) of ED diagnosis.  However, 43% of the women receiving routine healthcare that 
self-reported as White also had ED diagnoses indicating the comparison group had higher 
lifetime ED diagnoses overall.  One explanation for the higher rates could be the age (M 31.2; 
SD 6.5) of the women participants which is considerably older than the women studied in other 
ED research.  Finally, the higher percent of ED could be related to the specific comparison group 
recruitment setting that integrated mental health and psychiatry services into the internal 
medicine practices.  
Limitations 
  The limitations of the study were the use of convenience sampling, the recruitment 
settings, the comparison sample of women receiving routine healthcare at a general hospital 
medical center from their PCP and the use of self-report instruments. 
Convenience Sample.  The study used a convenience sample which limits generalization 
to other populations.  This sampling method is subject to bias, as people self-refer or volunteer.  
Additionally, women were given a stipend for participation where they could choose a gift card 
from one of four stores (two large pharmacy stores and two coffee and tea vendors).  Some 
women could have participated primarily due to the stipend.  Finally, the low number of 
Hispanic study participants also limits generalization.  Although overall minority representation 
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reflected that of the greater Boston area, only 3 women with infertility were Hispanic.  Two 
women in the comparison group were Hispanic, and another 5 women were unsure of their 
ethnicity. 
Recruitment Settings.  As with all research, approval to recruit at each site took time to 
negotiate.  The original recruitment plan was to have nurses review the daily patient flow, 
mention the study to appropriate women, and offer a brochure.  Each site reviewed the protocol 
and expressed realistic concern about the impact of recruitment disrupting patient care flow.  All 
sites finally agreed to allow placement of the study brochures in their waiting rooms for patients 
to self-refer.  Allowing patients to self-refer had a greater impact on the composition of the 
comparison group.  
Comparison group.  Women in the comparison group self-referred from the Women’s 
Center and internal medicine outpatient practice sites of a large academic medical center in the 
Boston metropolitan area.  Not as similar in the demographic characteristics, the comparison 
group had higher rates of ED than the women with infertility.  Finding a comparatively well 
group of women at the medical center was difficult, as not all healthy women under the age of 40 
generally have annual exams.   
The study brochures and the telephone screening highlighted that participants were to be 
medically stable.  Unfortunately, the notion of being medically stable was in the eye of the 
beholder, similar to what is clinically seen with women with ED.   Even women with BMIs in 
the extreme obesity range viewed themselves as medically stable.  Improved screening at the 
self-referral contact for current illnesses may have provided a sample more consistent with the 
wellness of women with infertility.  Because the comparison group is also a city sample, it is 
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difficult to generalize to the overall population of women receiving routine health care by their 
PCPs. 
Use of Self-Report Instruments.  The study employed self-report instruments that 
gathered an array of disordered ED attitudes and symptoms.  Garner (2004) suggested that 
guaranteeing confidentiality provides more truthful response.  In the present study participants 
were guaranteed confidentiality but not anonymity due to the possible need to further assess 
depression and anxiety symptoms.  Use of self-report was successful in the study; however, self-
report does not supplant in-person clinical research assessment in the accurate assessment of ED 
diagnoses.   
Recommendations for Future Research 
 The outcomes of this study provide further support that women with ovulatory and 
unexplained infertility are at risk for occult ED symptoms.  Women with ED may not 
realistically be able to report their symptoms.  Some women in the study, unprompted, openly 
mentioned their eating symptoms or exercise problem at screening and other women made no 
mention.  Likewise, the comparison group seemed unaware that extreme BMI is not consistent 
with medical stability.  More research is necessary before moving to examining nursing 
interventions in women with infertility that have ED.  Further study is needed to isolate 
biobehavioral predictor variables to help identify at risk women.  Also, qualitative study of 
women’s view of their eating symptoms and wellness may provide greater understanding of the 
ED population. 
Summary 
 The aim of the study was to investigate disordered eating and psychological symptoms in 
women with ovulatory and unexplained infertility compared with women receiving routine 
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health care from their PCP.  Hypothesis one stating that women with infertility would report 
significantly more eating disorder symptoms than the comparison group of women was partially 
upheld.  Women with infertility had significantly higher Desire for Thinness and Bulimia 
subscale scores.  The women receiving routine health care actually had significantly higher Body 
Dissatisfaction scores.  This was consistent with the comparison group having higher BMIs and 
ED on the overeating continuum.  Hypotheses 2a and 2b stating that women with infertility 
would report significantly more current and past ED diagnoses than the comparison group of 
women was not upheld.   Hypothesis 3 stating that women with infertility would report 
significantly more symptoms of depression, anxiety and dietary restraint than the comparison 
group of women was not upheld.  Instead, women receiving routine healthcare had higher 
Restraint scores, possibly contributing to dietary lapses.  Further study isolating biobehavioral 
marker variables identifying women at risk for ED was recommended.
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Verbal Informed Consent 
 
 
Study: Self-Report of Dietary and Psychological Symptoms by Women with 





You have been invited to take part in a research study titled, Self-Report of Dietary 
and Psychological Symptoms by Women with Ovulatory and Unexplained Infertility. The 
study explores aspects of dietary and emotional symptoms in women. You are being 
invited to take part in this research study because you are embarking on infertility 
treatment or have recently sought routine health care. If you take part in this study, you will 
be one of 200 women to do so. 
 
 Your participation is completely voluntary. Your decision whether or not to 
participate will have no effect on your relationship with your health care provider or affect 
your health care in any way. If there is anything you do not understand, please do not 
hesitate to ask questions. You may decide to not participate at any time. 
 
 The person doing this study is Ann Cousins, an advanced practice psychiatric 
nurse at BIDMC and a doctoral candidate at Boston College. No funding has been 
received in this study. Neither Ms. Cousins nor Professor Wolfe expects to receive any 
extra money from companies because of the research study. 
 
 To participate, please fill out the attached survey. The survey involves your report 
of dietary/eating and psychological symptoms you may have experienced. There is no cost 
to you for participation.  The information containing your responses to the survey will go 
directly to Boston College.  
 
 The survey takes from 30 to 40 minutes to complete. If you need more time, please 
limit yourself to 1 hour. Participating in the survey is not the same as seeking a 
professional evaluation or treatment. Should your responses suggest that consultation is 
recommended, I will call you to discuss possible referral. Please send the survey forms 
back in the postage-paid envelope addressed to Ann Cousins at Boston College. 
 
 Your name and your responses are confidential. No information is entered into 
your medical record. Additionally, your name will not be on the survey forms. Instead, your 
self-report forms will have a study ID number. Please leave your name off the survey 
documents and the return mailing envelope. Your responses will be kept in locked files in 
a locked room at Boston College, and the key to the study ID will be in a separate locked 
cabinet.  
 
To the best of my knowledge, filling out the survey will cause you no additional 
harm to you than what you would experience in everyday life. Your will receive a $30.00 
gift card in recognition of your participation. There will be no direct benefit to you for 
participating. 
 
 Returning your responses on the study questionnaires implies your consent. By 
consenting, you are allowing the investigators and other authorized personnel to use and 
disclose [to people at BIDMC and Boston College] Protected Health Information about 
you. This may include information about you that already exists such as the infertility type 
you may or may not currently experience, demographic information, as well as any new 
information generated from your responses on the questionnaires. This is your Protected 
Health Information. 
 
 Your Protected Health Information may be shared with investigators listed on this 
consent form as well as the supporting research team [i.e. research assistants and 
statistician]. Your Protected Health Information may also be shared with the Committee on 
Clinical Investigations of Beth Israel Deaconess Medical Center and the Boston College 
Institutional Review Board, as they are responsible for reviewing studies for the protection 
of the research subjects. The main reason for using and sharing your Protected Health 
Information is to conduct and oversee the research as described in this verbal Informed 
Consent. Your Protected Health Information may also be shared to ensure that the 
research meets legal, institutional and accreditation requirements and to conduct public 
health activities. 
 
 If you decide to take back your authorization so that your Protected Health 
Information can no longer be used in this study, please send a letter notifying the Principal 
Investigator of your withdrawal of your authorization to Ann Cousins, PhD candidate, 
APRN at Cushing Hall, Boston College, 140 Commonwealth Avenue, Chestnut Hill, MA 
02467. However, the investigators in this study will not be required to destroy or retrieve 
any of your Protected Health Information that has already been used or disclosed before 
the Principal Investigator receives your letter. 
  
You are encouraged to ask questions now and at any time. If you have further 
questions, please contact Ann Cousins at 617-785-0411 or Professor Wolfe at (617) 552-
1804. If you have questions about your rights as a research participant, please contact 
Boston College Office for Human Research Participant Protection at (617) 552-4778 or 
Beth Israel Deaconess Medical Center Office for Human Research Participant Protection 
at (617) 667-0469. Thank you very much. I look forward to hearing back from you. A letter 




Ageed to participate?  _______ Yes  ________ No 
 
_______________________        ____________________ 
Date      Time 






 Revised 11/24/08 
 









April 15, 2008                  
 
Dear Study Participant: 
 
You have been invited to take part in a research study titled, Self-Report of Dietary 
and Psychological Symptoms by Women with Ovulatory and Unexplained Infertility. The 
study explores aspects of dietary and emotional symptoms in women. You are being 
invited to take part in this research study because you are embarking on infertility 
treatment or have recently sought routine health care. If you take part in this study, you will 
be one of 200 women to do so. 
 
 Your participation is completely voluntary. Your decision whether or not to 
participate will have no effect on your relationship with your health care provider or affect 
your health care in any way. If there is anything you do not understand, please do not 
hesitate to ask questions. You may decide to not participate at any time. 
 
 The person doing this study is Ann Cousins, an advanced practice psychiatric 
nurse at BIDMC and a doctoral candidate at Boston College. No funding has been 
received in this study. Neither Ms. Cousins nor Professor Wolfe expects to receive any 
extra money from companies because of the research study. 
 
 To participate, please fill out the attached survey. The survey involves your report 
of dietary/eating and psychological symptoms you may have experienced. There is no cost 
to you for participation.  The information containing your responses to the survey will go 
directly to Boston College.  
 
 The survey takes from 30 to 40 minutes to complete. If you need more time, please 
limit yourself to 1 hour. Participating in the survey is not the same as seeking a 
professional evaluation or treatment. Should your responses suggest that consultation is 
recommended, I will call you to discuss possible referral. Please send the survey forms 
back in the postage-paid envelope addressed to Ann Cousins at Boston College. 
 
 Your name and your responses are confidential. No information is entered into 
your medical record. Additionally, your name will not be on the survey forms. Instead, your 
self-report forms will have a study ID number. Please leave your name off the survey 
documents and the return mailing envelope. Your responses will be kept in locked files in 
a locked room at Boston College, and the key to the study ID will be in a separate locked 
cabinet.  
 
To the best of my knowledge, filling out the survey will cause you no additional 
harm to you than what you would experience in everyday life. Your will receive a $30.00 
gift card in recognition of your participation. There will be no direct benefit to you for 
participating. 
 
 Returning your responses on the study questionnaires implies your consent. By 
consenting, you are allowing the investigators and other authorized personnel to use and 
disclose [to people at BIDMC and Boston College] Protected Health Information about 
you. This may include information about you that already exists such as the infertility type 
you may or may not currently experience, demographic information, as well as any new 
information generated from your responses on the questionnaires. This is your Protected 
Health Information. 
 
 Your Protected Health Information may be shared with investigators listed on this 
consent form as well as the supporting research team [i.e. research assistants and 
statistician]. Your Protected Health Information may also be shared with the Committee on 
Clinical Investigations of Beth Israel Deaconess Medical Center and the Boston College 
Institutional Review Board, as they are responsible for reviewing studies for the protection 
of the research subjects. The main reason for using and sharing your Protected Health 
Information is to conduct and oversee the research as described in this verbal Informed 
Consent. Your Protected Health Information may also be shared to ensure that the 
research meets legal, institutional and accreditation requirements and to conduct public 
health activities. 
 
 If you decide to take back your authorization so that your Protected Health 
Information can no longer be used in this study, please send a letter notifying the Principal 
Investigator of your withdrawal of your authorization to Ann Cousins, PhD candidate, 
APRN at Cushing Hall, Boston College, 140 Commonwealth Avenue, Chestnut Hill, MA 
02467. However, the investigators in this study will not be required to destroy or retrieve 
any of your Protected Health Information that has already been used or disclosed before 
the Principal Investigator receives your letter. 
  
You are encouraged to ask questions now and at any time. If you have further 
questions, please contact Ann Cousins at 617-785-0411 or Professor Wolfe at (617) 552-
1804. If you have questions about your rights as a research participant, please contact 
Boston College Office for Human Research Participant Protection at (617) 552-4778 or 
Beth Israel Deaconess Medical Center Office for Human Research Participant Protection 
at (617) 667-0469. Thank you very much. I look forward to hearing back from you. A letter 
summarizing this informed consent will be sent with the study packet. 







Ann Cousins, PhD(c), RN, CS.    Barbara Wolfe, PhD, RN, CS, FAAN 
       Dissertation Advisor 
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Study ID ~ Demographic Information Sheet Date: _--1__1 _ 
MM DO YYYY 
I. Age in whole years: __ years old 












3. What is your highest level of education (circle one)?
 
I Some high school 5 Bachelors degree
 
2 High school grad 6 Masters degree
 
3 Some college 7 Professional degree
 
4 Associate degree 8 PhD
 
4. What is your current work status (circle one)?
 
1 Currently working full-time
 
2 Currently working part-time (20 hours or less)
 
3 Not currently working outside of home
 
5.	 What is your income (circle one)? 6. Yours & spouse/partner combined income? 
1 Under $20,0001 Under $20,000 
2 $20,000 - $30.000 2 $20,000 - $30.000 
4 $30,000 - $40,000 4 $30,000 - $40,000 
5 $40,000 - $50,000 5 $40,000 - $50,000 
6 $50,000 - $75,000 6 $50,000 - $75,000 
7 $75,000 - $100,000 7 $75,000 - $100,000 
8 $100,000 - $150,000 8 100,000 - $150,000 
9 150,000 and above 9 $150,000 and above 
7. Are you currently experiencing infertility (circle one)? 
1 Yes If yes, were you told that the infertility was (circle one) 
lA Ovulatory or hormonal related? 
IB Unexplained? 
IC Other? Specify: _ 
2 No 








8. What is your ethnicity (circle one)?
 
1 Hispanic or Latino
 




9. What is your race? 
...•....... . . .
 
Self-Reported Race of All Participants: Self reported Race of AiiHi~panicand I 
. , Latino Participants I 
;1 American Indian or Alask~Nati~eli···Americ~I~di;;··orAiask~Nati~e-1 
2 Asian, East Southeast I 2 Asian, East Southeast
 
3 Asian, Western I 3 Asian, Western
 




5 Black or African American I 5 Black or African American
 
6 White I 6 White
 
7 Multi-Racial I 7 Multi-Racial
 
8 Unknown I 8 Unknown
 
9 Other I 9 Other
 
...._ ·······..H ·H··.·························· . 
See definitions below: 
Ethnic and Racial Definitions for the Categories Above: 
Hispanic and Latino: A Person ofCuban, Mexican, Puerto Rican, South or Central America or other 
Spanish culture or origin, regardless ofrace.
 
American Indian or A person having origins in any ofthe original peoples ofNorth, Central, or
 
Alaska Native: South America, and who maintains tribal affiliations or community attachment.
 




Western Asian: A person having origins in any ofthe original peoples ofthe Indian
 
subcontinent. This area includes, for example, India and Pakistan.
 
Native Hawaiian or A person having origins in any ofthe original peoples ofHawaii, Guam, Samoa,
 
Other Pacific Islander: or other Pacific Islands.
 




White: A person having origins in any ofthe original peoples ofEurope, the Middle
 
East, or North Africa. 
Thank you! Please compete the self-rating questionnaires and use the enclosed
 
investigator addressed envelope to mail back to Boston College.
 
For questions please call Ann Cousins, PhDc, RN, CS at 617-785-0411 
Approved 04/03/08 

Instruments        Available Through 
 
Eating Disorder Inventory-3-Referral Form   Psychological Assessment Resources 
        www.parinc.com 1.800.331.8378 
Eating Disorder Inventory-3-Symptom Checklist  Psychological Assessment Resources 
        www.parinc.com 1.800.331.8378 
Beck Depression Inventory     www.pearsonassessments.com 
 




This clinical research study asks women 
with infertility for their confidential self-
report of how they relate to food, patterns of 




 Who can participate? 
• Women currently 
experiencing ovulation 
problems or unexplained 
infertility;  
• Ages 18 to 44; and in 





Interested in learning about the 
study? 
• Leave a message on the 
confidential voicemail: 
617-785-0411 
• An advanced practice nurse 
will return your call on a day 
and time of your choosing to 
explain the study. 
• More information will be 
provided if you are 
interested in taking part in 
the study. 
• If you agree to take part, 
the questionnaires will be 
sent to you to fill out.  
• A postage paid envelope is 
provided for return of the 
questionnaires to Boston 
College. 
• Your responses are 
confidential and private. 
They will not be made part 
of your medical record.   
   
 
What’s involved? 
• Giving your confidential 
response to items on  
questionnaires; 
• 30 to 40 minutes of your time; 
and 
• Mailing the packet back to 
Boston College. 
• You will receive a $30.00 gift 
card to CVS or Walgreen’s, 








 Research Study 
Complete the survey in the 






 Needed  
Involving a 
Ages 18 to 44 
For a  
 William F. Connell School of 
Nursing                                
Boston College                          
140 Commonwealth Avenue                   
Chestnut Hill, MA 02467 
Ms. Cousins is a PhD candidate at: 
Ann Cousins, PhDc, RN, CS is a 
certified advanced practice nurse 
with a Beth Israel Deaconess 
Medical Center research group. 












Your participation in this study 
will help us learn whether or not 
certain lifestyle patterns and 
emotional symptoms occur more 
often in women with certain types 
of infertility compared to healthy 
women volunteers. 
To discuss participation or to 
receive more information, please 
contact: 
Ann Cousins, PhDc, RN, CS 









This clinical research study asks healthy 
women volunteers for their confidential self-
report of how they relate to food, patterns of 




Who can participate? 
• Healthy women receiving 
routine health care, 
• Not currently experiencing 
infertility; 
• Ages 18 to 44; and in 





Interested in learning about the 
study? 
• Leave a message on the 
confidential voicemail: 
617-785-0411 
• An advanced practice nurse 
will return your call on a day 
and time of your choosing to 
explain the study. 
• More information will be 
provided if you are 
interested in taking part in 
the study. 
• If you agree to take part, 
questionnaires will be sent 
to you to fill out.  
• A postage paid envelope is 
provided for return of the 
questionnaires to Boston 
College. 
• Your responses are 
confidential and private. 
They will not be made part 




• Giving your confidential 
response to items on  
questionnaires; 
• 30 to 40 minutes of your 
time; and 
• Mailing the packet back to 
Boston College. 
• You will receive a $30.00 gift 
card to CVS, Walgreen’s, 









Complete the survey in the 






 Needed  
Ages 18 to 44 
For a 
 William F. Connell School of 
Nursing                                
Boston College                          
140 Commonwealth Avenue                   
Chestnut Hill, MA 02467 
Ms. Cousins is a PhD candidate at: 
Ann Cousins, PhDc, RN, CS is a 
certified advanced practice nurse 
and a research nurse with a Beth 
Israel Deaconess Medical Center 
research group. 











Your participation in this study will 
help us learn whether or not certain 
lifestyle patterns and emotions 
occur more often in women with 
certain types of infertility compared 
to healthy women volunteers. 
To discuss participation or to 
receive more information, please 
contact: 
Ann Cousins, PhDc, RN, CS 
Participation is confidential! 
Contact Information: 









Ages 18 to 44  
For a 
Research Study 
Involving a  
Confidential Survey 
 
Complete the survey in the privacy of your 
own home. 
 
The study asks for your confidential self-report 
of dietary patterns, other lifestyle patterns and 
emotions.  
 
Women coming to the infertility center for 
evaluation and treatment are invited to consider 
participation in the study. 
  
For more information, please help yourself to a 
brochure.  
 
Principal Investigator: Ann Cousins, PhD Candidate, RN, CS 
This study is approved by the Beth Israel Deaconess Medical Center   
and Boston College.       07/23/08 
Healthy Women Volunteers Needed 
Ages 18 to 44 
For a  
Research Study  






Complete the survey in the privacy of your 
own home. 
 
The study asks for your confidential self-report 
of dietary patterns, other lifestyle patterns and 
emotions.  
 
Women coming to the center for a routine health           
visit are invited to consider participation in the 
study.  
 
For more information, please help yourself to a 
brochure. 
 
Principal Investigator: Ann Cousins, PhD Candidate, RN, CS. 
This study is approved by Beth Israel Deaconess Medical Center and 
Boston College.        07-23-08 
